EP2257326A2 - Pulverdispersionsgerät - Google Patents

Pulverdispersionsgerät

Info

Publication number
EP2257326A2
EP2257326A2 EP09722897A EP09722897A EP2257326A2 EP 2257326 A2 EP2257326 A2 EP 2257326A2 EP 09722897 A EP09722897 A EP 09722897A EP 09722897 A EP09722897 A EP 09722897A EP 2257326 A2 EP2257326 A2 EP 2257326A2
Authority
EP
European Patent Office
Prior art keywords
receptacle
feed tube
outlet
powder
puncturing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP09722897A
Other languages
English (en)
French (fr)
Inventor
Mark Glusker
William W. Alston
George S. Axford
John Palmer-Felgate
Jonathan Wilkins
Willard R. Foss
Nagaraja Rao
Mark Postich
Neeraj R. Pakala
David S. Maltz
Jeffry G. Weers
Gal Cohen
Keith Try Ung
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of EP2257326A2 publication Critical patent/EP2257326A2/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/001—Particle size control
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0005—Details of inhalators; Constructional features thereof with means for agitating the medicament
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0013—Details of inhalators; Constructional features thereof with inhalation check valves
    • A61M15/0016—Details of inhalators; Constructional features thereof with inhalation check valves located downstream of the dispenser, i.e. traversed by the product
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0033—Details of the piercing or cutting means
    • A61M15/0035—Piercing means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0033—Details of the piercing or cutting means
    • A61M15/0038—Cutting means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0033—Details of the piercing or cutting means
    • A61M15/0041—Details of the piercing or cutting means with movable piercing or cutting means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder

Definitions

  • the present invention relates generally to methods and apparatuses for the pulmonary delivery of a composition.
  • the invention relates to methods and apparatuses for dispersing dry powder medicaments for inhalation by a patient.
  • the invention is also directed to elements or aspects of the apparatuses as noted; such aspects include receptacle puncturing mechanisms, deocculsion devices, receptacle impacting devices, and receptacle lock devices or systems.
  • Such elements or aspects can be used in apparatuses, including for example, apparatuses for pulmonary delivery of a composition.
  • Effective delivery to a patient is an important aspect of any successful drug therapy.
  • Oral drug delivery of pills, capsules, elixirs, and the like, is perhaps the most convenient method, but many drugs are degraded in the digestive tract before they can be absorbed. Such degradation can be particularly problematic with protein drugs which can be rapidly degraded by proteolytic enzymes in the digestive tract.
  • Subcutaneous injection is frequently an effective route for systemic drug delivery, including the delivery of proteins, but generally suffers from low patient acceptance.
  • pulmonary drug delivery involves inhalation of a drug, such as in a dispersion or aerosol, by the patient so that active drug can reach the distal (alveolar) regions of the lung. It has been found that certain drugs are readily absorbed through the alveolar region directly into blood circulation. Pulmonary delivery is particularly promising for the delivery of proteins and polypeptides which are difficult to deliver by other routes of administration. Such pulmonary delivery is effective both for systemic delivery and for localized delivery to treat diseases of the lungs. A non-limiting example of local delivery is delivery of anti-infectives, such as antifungals and antivirals.
  • Pulmonary drug delivery can itself be achieved by different approaches, including liquid nebulizers, pressurized metered dose inhalers (pMDI's), and dry powder dispersion devices. Dry powder dispersion devices are particularly promising for delivering certain drugs, such as proteins and polypeptides, which may be readily formulated as dry powders. Many otherwise labile proteins and polypeptides may be stably stored as lyophilized or spray-dried powders by themselves or in combination with suitable powder carriers. The ability to deliver proteins and polypeptides as dry powders, however, can be difficult in certain respects.
  • One approach for the pulmonary delivery of dry powder drugs utilizes a hand-held device with a pump or other source of pressurized gas.
  • a selected amount of the pressurized gas is abruptly released through a powder dispersion device, such as a Venturi tube, and the dispersed powder made available for patient inhalation.
  • a powder dispersion device such as a Venturi tube
  • Another typical characteristic for hand-held and other powder delivery devices is high dosage concentration. It is important that the concentration of drug in the bolus of gas be relatively high to reduce the number of breaths and/or volume of each breath required to achieve a total dosage. The ability to achieve both adequate dispersion and small dispersed volumes is a significant technical challenge.
  • Dry powder dispersion devices for medicaments are described in a number of patent documents. For example, U.S. Pat.
  • No. 3,921,637 describes a manual pump with needles for piercing through a single capsule of powdered medicine.
  • the use of multiple receptacle disks or strips of medication is described, for example, in EP 467172 (in which a reciprocatable piercing mechanism is used to pierce through opposed surfaces of a blister pack); WO91/02558; WO93/09832; WO94/08522; U.S. Pat. Nos. 4,627,432; 4,811 ,731 ; 5,035,237; 5,048,514; 4,446,862; and 3,425,600.
  • an apparatus includes a pressurization cylinder and a piston which is slidable within the cylinder to pressurize a gas.
  • a handle is coupled to the piston and is movable between an extended position and a home position to pressurize the gas.
  • An aerosolizing mechanism is included and is configured to aerosolize a powdered medicament that is held within a receptacle with pressurized gas from the cylinder.
  • a carriage assembly is included to receive the receptacle and to couple the receptacle to the aerosolizing mechanism.
  • a first and a second interlock are operably engageable with the carriage assembly to prevent coupling of the receptacle with the aerosolization mechanism.
  • the first interlock is released to allow movement of the carriage upon movement of the handle to the extended position.
  • the second interlock remains engaged if the receptacle is only partially inserted into the carriage assembly, lnhaleable insulin utilized a device similar to that described in U.S. Pat. No. 6,257,233, as an alternative to injections for the first time.
  • Diskhaler® drives a long plastic tooth through the entire drug package, retracting it before inhalation. This creates an additional step to retract the tooth, ends up creating a large and inconsistent hole through the drug package, and produces variable dose due to airflow variation and powder losses through the large hole.
  • the Diskus® peels away the thin lidstock, revealing the entire tub containing the drug powder. The act of peeling back the lidstock creates vibrations in the drug package, which create a risk of vibrating powder out of the drug package and reducing the available dose.
  • the present invention provides a variety of mechanisms and methods, which may be used in pulmonary delivery of substances, such as drugs, and in other applications.
  • substances such as drugs, and in other applications.
  • Other features and advantages of the present invention will be set forth in the description of invention that follows, and in part will be apparent from the description or may be learned by practice of the invention. The invention will be realized and attained by the mechanisms and methods particularly pointed out in the written description and claims hereof.
  • aspects of the invention relate generally to methods and apparatuses for the pulmonary delivery of a substance such as drugs.
  • the present invention relates to methods and apparatuses for dispersing dry powder medicaments for inhalation by a patient.
  • Embodiments also include elements such as receptacle puncturing mechanisms, deoccluding elements, receptacle impacting elements, and receptacle lock elements. Such features or elements can be used alone or in combination with one or more other features or elements. Such features and elements can be used in apparatuses for the pulmonary delivery of drugs, or in any other apparatus, including those not intended for delivery of drugs. [019] In one aspect, the present invention involves an apparatus comprising a support for supporting a receptacle, an outlet, and a feed tube communicating with the outlet.
  • the apparatus also includes a mechanism configured to create at least one opening in a wall of the receptacle, the mechanism comprising a blade having a leading edge, wherein the leading edge comprises an elliptical leading edge having a rho value from 0.1 to 0.5.
  • the present invention involves an apparatus comprising a support for supporting a receptacle, an outlet, and a feed tube communicating with the outlet.
  • the apparatus also includes a deoccluding device permanently arranged within the feed tube.
  • the present invention involves an apparatus comprising a support for supporting a receptacle, an outlet, and a feed tube communicating with the outlet.
  • the apparatus also includes a receptacle impacting device that has a plurality of stable positions such that the receptacle impacting device is automatically cocking.
  • the present invention involves an apparatus comprising a support for supporting a receptacle having an outline comprising a first pair of sides and a second pair of sides that are shorter than the first pair of sides, the first pair of sides comprising notches.
  • the apparatus also includes an outlet and a feed tube communicating with the outlet.
  • the apparatus includes a receptacle lock system that interacts with the notches of the receptacle.
  • the present invention involves a method of opening a receptacle using an apparatus.
  • the method includes inserting a receptacle containing a powder into the apparatus.
  • the method further includes creating, with a mechanism configured to create at least one opening in a wall of the receptacle, a puncture in the wall and then a tear in the wall, wherein the tearing bends torn edges of the wall inwardly into the receptacle.
  • the present invention involves using an apparatus.
  • the method includes inserting a receptacle containing a powder into the apparatus, puncturing the receptacle, and deoccluding a feed tube of the apparatus.
  • the present invention involves a method of using an apparatus.
  • the method includes inserting a receptacle containing a powder into the apparatus and impacting the receptacle with a receptacle impacting device.
  • the present invention involves a mechanism configured to create at least one opening in a wall of a receptacle.
  • the mechanism includes a support and at least one protruding member arranged on the support.
  • the at least one protruding member comprising a blade having a leading edge, wherein the leading edge comprises an elliptical leading edge having a rho value from 0.1 to 0.5.
  • the present invention involves a deoccluding device adapted to remove a powder residue from an inner surface of a tube.
  • the device includes a first portion structured and arranged to deocclude an inner surface of a tube by rotating and descending into the tube, wherein the first portion does not contact the inner surface of the tube.
  • the present invention involves a receptacle impacting device.
  • the receptacle impacting device includes a support portion and a plurality of arms projecting from the support portion. Each of the plurality of arms is structured and arranged to impact a receptacle.
  • the present invention includes a receptacle lock system structured and arranged to receive a receptacle of predetermined configuration.
  • the system includes a device that moves from a locked position to an unlocked position based on a position of the receptacle, wherein the receptacle comprises an outline comprising a first pair of sides and a second pair of sides that are shorter than the first pair of sides, the first pair of sides comprising notches, and wherein the receptacle lock system interacts with the notches of the receptacle.
  • the present invention involves a kit including (1) an apparatus; and (2) at least one powder-containing receptacle.
  • the apparatus comprises a support for supporting a receptacle, an outlet, and a feed tube communicating with the outlet.
  • the apparatus also includes at least one of: a mechanism configured to create at least one opening in a wall of a receptacle, the mechanism comprising a blade having a leading edge, wherein the leading edge comprises an elliptical leading edge having a rho value from 0.1 to 0.5; a deoccluding device permanently arranged within the feed tube; a receptacle impacting device that has a plurality of stable positions such that the receptacle impacting device is automatically cocking; and a receptacle lock system that interacts with notches of the receptacle wherein the receptacle has an outline comprising a first pair of sides and a second pair of sides that are shorter than the first pair of sides, the first pair of sides comprising the notches; and [031]
  • the present invention includes a combination comprising (1) an apparatus; and (2) a powder-
  • the apparatus comprises a support for supporting a receptacle, an outlet, a feed tube communicating with the outlet, and at least one of: i) a mechanism configured to create at least one opening in a wall of a receptacle, the mechanism comprising a blade having a leading edge, wherein the leading edge comprises an elliptical leading edge having a rho value from 0.1 to 0.5; ii) a deoccluding device permanently arranged within the feed tube; iii) a receptacle impacting device that has a plurality of stable positions such that the receptacle impacting device is automatically cocking; and iv) a receptacle lock system that interacts with notches of the receptacle wherein the receptacle has an outline comprising a first pair of sides and a second pair of sides that are shorter than the first pair of sides, the first pair of sides comprising the notches.
  • the present invention involves an apparatus comprising an outlet, a feed tube communicating with the outlet, a mechanism configured to create at least one opening in a wall of a receptacle, a deoccluding device arranged within the feed tube, a receptacle impacting device, and a receptacle lock system.
  • the present invention involves a method of aerosolizing a powder using an apparatus.
  • the method includes inserting a receptacle containing a powder into the apparatus, rotating one portion of a housing relative to another portion of the housing, and inhaling on a mouthpiece of the apparatus.
  • the present invention involves a kit comprising components for assembling an apparatus.
  • the apparatus includes at least an outlet, a feed tube communicating with the outlet, a mechanism configured to create at least one opening in a wall of a receptacle, a deoccluding device arranged within the feed tube, a receptacle impacting device, a receptacle lock system, and written instructions for assembling the components into an apparatus for aerosolizing a powder.
  • the present invention involves an apparatus comprising a support for supporting a receptacle, an outlet, and an internally flared feed tube communicating with the outlet.
  • the apparatus also includes a mechanism configured to create at least one opening in a wall of the receptacle, the mechanism comprising a blade having a leading edge, wherein the leading edge comprises an elliptical leading edge having a rho value from 0.1 to 0.5.
  • the present invention involves an apparatus comprising a support for supporting a receptacle, an outlet, and an internally flared feed tube communicating with the outlet.
  • the apparatus also includes a mechanism configured to create at least one opening in a wall of the receptacle, the mechanism comprising a blade having a leading edge, wherein the leading edge comprises an elliptical leading edge having a rho value from 0.1 to 0.5.
  • the present invention involves a method of administering a drug-containing powder via inhalation.
  • the method include inserting a powder-containing receptacle into an apparatus for aerosolizing a powder, the apparatus comprising a support for supporting a receptacle, an outlet, a feed tube providing communication between the receptacle and the outlet, and at least one of: i) a mechanism configured to create at least one opening in a wall of the receptacle, the mechanism comprising a blade having a leading edge, wherein the leading edge comprises an elliptical leading edge having a rho value from 0.1 to 0.5; ii) a deoccluding device arranged within the feed tube; iii) a receptacle impacting device; and iv) a receptacle lock system; and producing at least one opening in the powder-containing receptacle; and inhaling on a mouthpiece of the apparatus, whereby powder in the powder-containing receptacle is administered.
  • a mechanism configured to create at least one opening in a wall of the recept
  • the present invention involves an apparatus comprising a support for supporting a receptacle, an outlet, and a feed tube communicating with the outlet.
  • the apparatus also includes a valve positioned between the receptacle and the outlet such that air flow from the receptacle to the outlet passes through the valve.
  • the present invention involves a cutter mechanism.
  • the cutter mechanism includes a plastic blade having a leading edge, wherein the leading edge comprises an elliptical leading edge having a rho value from 0.1 to 0.5.
  • the present invention involves an apparatus including a support for supporting a receptacle, an outlet, and a feed tube communicating with the outlet.
  • the apparatus also includes a puncturing device disposed in the feed tube, wherein the puncturing device is moveable relative to the feed tube to puncture the receptacle.
  • the present invention involves a receptacle.
  • the receptacle includes a lower foil laminate comprising a blister for holding powder and an upper foil laminate covering the lower foil laminate, wherein the receptacle comprises a rear portion having two sides perpendicular to a third side, a middle portion comprising notches, and a tapered front portion.
  • Further embodiments comprise any two or more of any of the foregoing features, aspects, versions or embodiments.
  • FIG. 1 shows a front side view of one embodiment of the invention and includes an overall height dimension and an overall width dimension;
  • FIG. 2 shows a front side view of the embodiment of FIG. 1 with the cover removed;
  • FIG. 3 shows a side perspective view of an embodiment of the invention and illustrates how the cover can be removed by lifting it vertically off of the device;
  • FIG. 4 shows another side perspective view of the embodiment of FIG. 3 and illustrates how the receptacle can be inserted into the front side of the device after the cover has been removed.
  • the lock system is engaged and the receptacle impacting system is activated;
  • FIG. 5 shows another side perspective view of the embodiment of FIG. 4 and illustrates how the mouth piece or upper portion of the device can be rotated relative to a lower portion of the device after the receptacle has been properly inserted. Rotation of 180 degrees automatically causes puncturing and tearing of both the inlet and outlet openings in the receptacle and deoccluding of the feed tube;
  • FIG. 6 shows another side perspective view of the embodiment of FIG. 5 and illustrates how, after the mouth piece is rotated 180 degrees, the device can be used by the user for inhalation;
  • FIG. 7 shows another side perspective view of the embodiment of FIG. 6 and illustrates how the receptacle can be removed;
  • FIG. 8 shows another side perspective view of the embodiment of FIG. 7 and illustrates how the cover can be placed back onto the device after use;
  • FIG. 9 shows an exploded view of another embodiment of the invention.
  • FIG. 10 shows how the deoccluding device and the cutter mechanism shown in FIG. 9 are assembled together;
  • FIG. 11 shows how the orifice member and the subassembly shown in FIG. 10 are assembled together
  • FIG. 12 shows how the trigger member and the subassembly shown in FIG. 11 are assembled together
  • FIG. 13 shows how the retainer member and the subassembly shown in FIG. 12 are assembled together
  • FIG. 14 shows how the upper bearing member and the lower bearing member shown in FIG. 9 are assembled together
  • FIG. 15 shows how the subassembly shown in FIG. 13 and the subassembly shown in FIG. 14 are assembled together;
  • FIG. 16 shows how the coil spring and the subassembly shown in
  • FIG. 15 are assembled together
  • FIG. 17 shows how the mouth piece and the subassembly shown in
  • FIG. 16 are assembled together
  • FIG. 18 shows how the bottom housing member and the torsion spring shown in FIG. 9 are assembled together
  • FIG. 19 shows how the receptacle impacting mechanism and the subassembly shown in FIG. 18 are assembled together;
  • FIG. 20 shows how the lock member and the subassembly shown in FIG. 19 are assembled together
  • FIG. 21 shows how the skirt member and the subassembly shown in FIG. 20 are assembled together
  • FIG. 22 shows how the body member and the subassembly shown in FIG. 21 are assembled together
  • FIG. 23 shows how the subassembly shown in FIG. 17 and the subassembly shown in FIG. 22 are assembled together;
  • FIG. 24 shows how the cover member and the subassembly shown in FIG. 23 are assembled together
  • FIG. 25 shows a cut-away rear-side view of the embodiment shown in FIG. 24 with a receptacle installed therein.
  • the trigger is shown in both the closed position and the open position
  • FIG. 26 shows a cut-away right-side view of the embodiment shown in FIG. 24 with a receptacle installed therein.
  • the trigger is shown in both the closed position and the open position;
  • FIG. 27 shows a partially cut-away front side perspective view of the embodiment shown in FIG. 24 with a receptacle installed therein.
  • the trigger is shown in both the closed position and the open position;
  • FIG. 28 shows a top view of the cap shown in FIG. 9;
  • FIG. 29 shows a front side view of the cap shown in FIG. 28;
  • FIG. 30 shows a top front perspective view of the cap shown in
  • FIG. 28
  • FIG. 31 shows a rear bottom perspective view of the cap shown in
  • FIG. 28
  • FIG. 32 shows a top view of the mouthpiece shown in FIG. 9;
  • FIG. 33 shows a front side view of the mouthpiece shown in FIG.
  • FIG. 34 shows a front side cross-section view of the mouthpiece shown in FIG. 32;
  • FIG. 35 shows a right side view of the mouthpiece shown in FIG.
  • FIG. 36 shows a bottom view of the mouthpiece shown in FIG. 32;
  • FIG. 37 shows a top front perspective view of the mouthpiece shown in FIG. 32;
  • FIG. 38 shows a right side cross-section view of the mouthpiece shown in FIG. 32;
  • FIG. 39 shows a rear bottom perspective view of the mouthpiece shown in FIG. 32;
  • FIG. 40 shows a top view of the retainer shown in FIG. 9;
  • FIG. 41 shows a front side view of the retainer shown in FIG. 40;
  • FIG. 42 shows a right side cross-section view of the retainer shown in FIG. 40;
  • FIG. 43 shows a rear bottom perspective view of the retainer shown in FIG. 40;
  • FIG. 44 shows a top view of the trigger shown in FIG. 9;
  • FIG. 45 shows a front side view of the trigger shown in FIG. 44;
  • FIG. 46 shows a top front perspective view of the trigger shown in
  • FIG. 44
  • FIG. 47 shows a rear bottom perspective view of the trigger shown in FIG. 44;
  • FIG. 48 shows a front side view of the orifice member shown in
  • FIG. 9 is a diagrammatic representation of FIG. 9
  • FIG. 49 shows a bottom rear side perspective view of the orifice member shown in FIG. 48;
  • FIG. 50 shows a top side perspective view of the orifice member shown in FIG. 48;
  • FIG. 51 shows a front side view of the deoccluding member shown in FIG. 9;
  • FIG. 52 shows a top left side view of the deoccluding member shown in FIG. 51 ;
  • FIG. 53 shows a top view of the cutter mechanism shown in FIG. 9;
  • FIG. 54 shows a front side view of the cutter mechanism shown in
  • FIG. 53
  • FIG. 55 shows a front side cross-section view of the cutter mechanism shown in FIG. 53;
  • FIG. 56 shows a bottom view of the cutter mechanism shown in
  • FIG. 53
  • FIG. 57 shows a right side view of the cutter mechanism shown in
  • FIG. 53
  • FIG. 58 shows a top front perspective view of the cutter mechanism shown in FIG. 53;
  • FIG. 59 shows a bottom left side perspective view of the cutter mechanism shown in FIG. 53;
  • FIG. 60 shows a top view of the upper bearing member shown in
  • FIG. 9 is a diagrammatic representation of FIG. 9
  • FIG. 61 shows a front side view of the upper bearing member shown in FIG. 60;
  • FIG. 62 shows a front side cross-section view of the upper bearing member shown in FIG. 60;
  • FIG. 63 shows a bottom view of the upper bearing member shown in FIG. 60;
  • FIG. 64 shows a top right front perspective view of the upper bearing member shown in FIG. 60;
  • FIG. 65 shows a bottom rear side perspective view of the upper bel ⁇ ngimerriber sffbwnjiE.FltB. 60;
  • FIG. 66 shows a top view of the lower bearing member shown in
  • FIG. 9 is a diagrammatic representation of FIG. 9
  • FIG. 67 shows a front side view of the lower bearing member shown in FIG. 66;
  • FIG. 68 shows a front side cross-section view of the lower bearing member shown in FIG. 66;
  • FIG. 69 shows a bottom view of the lower bearing member shown in FIG. 66;
  • FIG. 70 shows a right side view of the lower bearing member shown in FIG. 66;
  • FIG. 71 shows a top right front perspective view of the lower bearing member shown in FIG. 66;
  • FIG. 72 shows a bottom rear side perspective view of the lower bearing member shown in FIG. 66;
  • FIG. 73 shows a top view of the body member shown in FIG. 9;
  • FIG. 74 shows a front side view of the body member shown in FIG.
  • FIG. 75 shows a front side cross-section view of the body member shown in FIG. 73;
  • FIG. 76 shows a bottom view of the body member shown in FIG.
  • FIG. 77 shows a top right front perspective view of the body member shown in FIG. 73;
  • FIG. 78 shows a bottom rear side perspective view of the body member shown in FIG. 73;
  • FIG. 79 shows a top view of the skirt shown in FIG. 9;
  • FIG. 80 shows a front side view of the skirt shown in FIG. 79; [0123] FIG. 81 shows a front side cross-section view of the skirt shown in
  • FIG. 79
  • FIG. 82 shows a top right front perspective view of the skirt shown in FIG. 79;
  • FIG. 83 shows a bottom rear side perspective view of the skirt shown in FIG. 79;
  • FIG. 84 shows a top view of the lock member shown in FIG. 9;
  • FIG. 85 shows a right side view of the lock member shown in FIG.
  • FIG. 86 shows a top right front perspective view of the lock member shown in FIG. 84;
  • FIG. 87 shows a bottom rear side perspective view of the lock member shown in FIG. 84;
  • FIG. 88 shows a right side partial cross-section view of the receptacle impacting member shown in FIG. 9;
  • FIG. 89 shows a right side cross-section view of the receptacle impacting member shown in FIG. 88;
  • FIG. 90 shows a front side view of the receptacle impacting member shown in FIG. 88;
  • FIG. 91 shows a right side view of the receptacle impacting member shown in FIG. 88;
  • FIG. 92 shows a right front perspective view of the receptacle impacting member shown in FIG. 88;
  • FIG. 93 show a top right front perspective view of the coil spring shown in FIG. 9;
  • FIG. 94 shows a top right front perspective view of the torsion spring shown in FIG. 155;
  • FIG. 95 shows a top view of the bottom or lower housing member shown in FIG. 9;
  • FIG. 96 shows a front side view of the bottom or lower housing member shown in FIG. 95;
  • FIG. 97 shows a top right front perspective view of the bottom or lower housing member shown in FIG. 95;
  • FIG. 98 shows a left bottom rear side perspective view of the bottom or lower housing member shown in FIG. 95;
  • FIG. 99 shows a rear bottom perspective view of a trigger of the type shown in FIG. 9 in the open position
  • FIG. 100 shows a flow rate chart illustrating flow rates through a device which does not utilize a trigger of the type disclosed herein;
  • FIG. 101 shows a flow rate chart illustrating flow rates through a device which does utilize a trigger of the type disclosed herein;
  • FIG. 102 shows a top view of a punctured foil lid of a receptacle after being used in an inhalation apparatus of the type described herein and illustrates the two curved inlet openings and the center outlet opening;
  • FIG. 103 shows a cut-away view of a bottom portion of an apparatus according to the invention with a receptacle installed therein;
  • FIG. 104 shows a cut-away view of a bottom portion of an apparatus according to the invention and shows an initial insertion position of the receptacle into the apparatus.
  • the leading edge of the receptacle has passed between an arm of the receptacle impacting member and a bottom surface of the lower bearing member and the front curved surface of the tub portion of the receptacle has come into contact with the arm of the receptacle impacting member;
  • FIG. 105 shows another cut-away view of FIG. 104 and shows an intermediate insertion position of the receptacle into the apparatus.
  • the front curved surface of the tub portion of the receptacle has caused the arm of the receptacle impacting member to move or partially rotate clockwise causing the receptacle impacting member to also move downwards against the biasing force of the torsion spring;
  • FIG. 106 shows another cut-away view of FIG. 104 and shows another intermediate insertion position of the receptacle into the apparatus.
  • FIG. 107 shows another cut-away view of FIG. 104 and shows the final insertion position of the receptacle into the apparatus.
  • FIG. 108 shows a top view of the receptacle shown in FIG. 9;
  • FIG. 109 shows a front side view of the receptacle shown in FIG. 108;
  • FIG. 110 shows a bottom view of the receptacle shown in FIG. 108;
  • FIG. 111 shows a top right front side perspective view of the receptacle shown in FIG. 108;
  • FIG. 112 shows a partial flow diagram illustrating air flow into the receptacle from the inlet openings towards the center of the receptacle tub, and then up through the center opening of the receptacle and then finally up through the feed tube and past the deoccluding member;
  • FIG. 113 shows front and side flow diagrams illustrating total air flow through the inhalation apparatus;
  • FIGS. 114-123 show various cross-section views of the inhalation apparatus as it is being used and from different angles and positions;
  • FIG. 124 shows an enlarged left side view of an exemplary cutter mechanism which can be used in the inhalation apparatus;
  • FIG. 125 shows a top view of the cutter mechanism shown in FIG. 124;
  • FIG. 126 shows a section view of FIG. 124 and shows a rotational direction of movement of the teeth which will form the inlet openings in the receptacle;
  • FIG. 127 shows one of the teeth of FIG. 126 and non-limiting cross- sectional height and width dimensions in millimeters thereof;
  • FIG. 128 shows an exploded view of another embodiment of the invention;
  • FIG. 129 shows a perspective view of a mouthpiece of the embodiment shown in FIG. 128;
  • FIG. 130 shows a perspective view of an adapter of the embodiment shown in FIG. 128;
  • FIG. 131 shows a perspective view of a deoccluding device of the embodiment shown in FIG. 128;
  • FIG. 132 shows a perspective view of a cutter mechanism of the embodiment shown in FIG. 128;
  • FIG. 133 shows a perspective view of a bearing member of the embodiment shown in FIG. 128;
  • FIG. 134 shows a perspective view of a body of the embodiment shown in FIG. 128;
  • FIG. 135 shows a perspective view of a tray of the embodiment shown in FIG. 128;
  • FIG. 136 shows a perspective view of a receptacle impacting member of the embodiment shown in FIG. 128;
  • FIG. 137 shows a perspective view of a baseplate of the embodiment shown in FIG. 128;
  • FIG. 138 shows a perspective view of a skirt member of the embodiment shown in FIG. 128;
  • FIGS. 139-178 show various diagrams and drawings relating to air flow characteristics of an apparatus of the invention.
  • FIG. 179 shows the rho dimension of a conic segment PQ.
  • FIGS. 180-182 show baseplates with biasing mechanisms.
  • the invention is directed to methods and apparatuses for the pulmonary delivery of a substance such as drugs. More particularly, the present invention relates to a method and apparatus for dispersing dry powder medicaments for inhalation by a patient.
  • the invention is also directed to devices, which can be used in or on such devices such as a receptacle puncturing mechanism, a deoccluding device, a receptacle impacting device, and a receptacle lock device or system. Such features can be used alone or in combination with an apparatus according to the invention.
  • a reference to a compound or component includes the compound or component by itself, as well as in combination with other compounds or components, such as mixtures of compounds.
  • a composition that is "suitable for pulmonary delivery” refers to a composition that is capable of being aerosolized and inhaled by a subject so that a portion of the aerosolized particles reaches the lungs, e.g., to permit entry into the alveoli and into the blood. Such a composition may be considered “respirable” or “inhaleable.”
  • An "aerosolized” composition contains liquid or solid particles that are suspended in a gas (typically air), typically as a result of actuation (or firing) of an inhalation device.
  • a passive dry powder inhaler would be actuated by a user's breath.
  • a "dry powder inhaler” is a device that is loaded with a unit dose of the drug in powder form. Generally, the inhaler is activated by taking a breath.
  • a capsule or blister is punctured and the powder is dispersed so that it can be inhaled, e.g., in a "Spinhaler” or “Diskhaler.”
  • “Turbohalers” are fitted with canisters that deliver measured doses of the drug in powder form.
  • the term "emitted dose” or "ED" refers to an indication of the delivery of dry powder from an inhaler device after an actuation or dispersion event from a powder unit or reservoir.
  • ED is defined as the ratio of the dose delivered by an inhaler device to the nominal dose (i.e., the mass of powder per unit dose placed into a suitable inhaler device prior to firing).
  • the ED is an experimentally determined amount, and may be determined using an in vitro device set up which mimics patient dosing. In one exemplary method to determine an ED value, as used herein, dry powder is placed into a device to be tested.
  • the device is actuated (e.g., by inserting a blister, rotating a mouthpiece of the device, and applying a 30 Umin, unless otherwise specified, vacuum source to an exit of the mouthpiece), dispersing the powder.
  • the resulting aerosol cloud is then drawn from the device by vacuum (30 L/min) for 2.5 seconds after actuation, where it is captured on a tared glass fiber filter (Gelman, 47 mm diameter) attached to the device mouthpiece.
  • the vacuum source may be applied at other rates, such as 47 L/min.
  • the amount of powder that reaches the filter constitutes the delivered dose.
  • a composition in "dry powder form” is a powder composition that typically contains less than about 20 wt% moisture.
  • MMD mass median diameter
  • a plurality of particles typically in a polydisperse particle population, i.e., consisting of a range of particle sizes. MMD values as reported herein are determined by laser diffraction (Sympatec Helos, Clausthal-Zellerfeld, Germany), unless the context indicates otherwise.
  • powder samples are added directly to the feeder funnel of the Sympatec RODOS dry powder dispersion unit. This can be achieved manually or by agitating mechanically from the end of a VIBRI vibratory feeder element.
  • Samples are dispersed to primary particles via application of pressurized air (2 to 4 bar), with vacuum depression (suction) maximized for a given dispersion pressure.
  • Dispersed particles are probed with a 632.8 nm laser beam that intersects the dispersed particles' trajectory at right angles.
  • Laser light scattered from the ensemble of particles is imaged onto a concentric array of photomultiplier detector elements using a reverse-Fourier lens assembly. Scattered light is acquired in time-slices of 5 ms.
  • Particle size distributions are back-calculated from the scattered light spatial/intensity distribution using an algorithm.
  • Mass median aerodynamic diameter is a measure of the aerodynamic size of a dispersed particle.
  • the aerodynamic diameter is used to describe an aerosolized powder in terms of its settling behavior, and is the diameter of a unit density sphere having the same settling velocity, in air, as the particle.
  • the aerodynamic diameter encompasses particle shape, density, and physical size of a particle.
  • MMAD refers to the midpoint or median of the aerodynamic particle size distribution of an aerosolized powder determined by cascade impaction at standard conditions (20 0 C; 40% RH) using the device to be tested.
  • Fine particle fraction is the fraction of particles with an aerodynamic diameter that is less than a specified size, such as 5 microns ( ⁇ m). Where specified, the fine particle fraction may also refer to the fraction of particles with an aerodynamic diameter that is less than aspecified size, such as 3.3 microns. These values are used herein, unless otherwise noted.
  • Fine particle dose is the amount of particles with an aerodynamic diameter that is less than a specified size, such as 5 microns ( ⁇ m). Where specified, the fine particle dose may also refer to the amount of particles with an aerodynamic diameter that is less than a specified size, such as 3.3 microns. These values are used herein, unless otherwise noted.
  • Receptacle is a container.
  • a receptacle may be a unit dose receptacle, or it may be a reservoir having multiple doses.
  • unit dose receptacles include blister packs and capsules.
  • the receptacle may be removable from an inhaler device, or the receptacle may be part of an inhaler device.
  • the receptacle typically comprises any material that allows tearing, e.g., a controlled tear, such as foil-plastic laminates.
  • “Tearing” means to pull apart.
  • a blade may be used to tear a material so long as the material pulls apart at a distance from a leading edge of the blade.
  • "Cutting” means to divide.
  • a blade may be used to cut a material such that a leading edge of the blade contacts the material to be cut.
  • the "rho" dimension of a conic segment PQ defines the shape of the conic (see FIG. 179).
  • the rho dimension specifies a ratio along a vector from the chord (PQ) through a point C to the vertex (R).
  • Point C is at the maximum distance (CD), measured by a normal from the chord PQ to the conic segment PQ.
  • Rho is a/(a+b).
  • One aspect of the invention relates to a mechanism configured to cut or tear materials.
  • This aspect of the present invention may be used for most any application in which cutting or tearing is desired.
  • the blades of the present invention may be used in the food packaging field.
  • the mechanism may be configured to create at least one air inlet opening in a wall of a receptacle by causing a puncture in the wall and also causing a controlled tearing of the wall, whereby the tearing may bend torn edges of the wall inwardly (see e.g., FIG. 102).
  • such a mechanism can be utilized in the apparatus and/or method for aerosolizing a powdered medicament as described herein (see e.g., FIGS. 1-9, 24-27, and 114-123).
  • the receptacle can take the form of a primary drug package which is sealed against moisture using a foil that spans the tub containing the powder (see e.g., FIGS. 108- 111).
  • puncturing of the foil in a substantially controlled fashion is desired. This control can be performed effectively using one or more substantially tooth- shaped members (see e.g., FIGS. 126-127).
  • the tooth (or teeth), which performs the controlled puncturing generally first moves into engagement with the package (e.g., by moving the tooth toward the package or by moving the package toward the tooth).
  • the receptacle remains static (neither raised nor lowered) in the apparatus and instead the receptacle puncturing mechanism moves vertically to a lower position, wherein the receptacle is punctured, and also to an upper or retracted position.
  • This degree of movement should be sufficient to cause the foil of the package to be punctured. This generally occurs when the foil is locally, i.e., in the vicinity of the tooth, stretched beyond its ability to resist plastic deformation.
  • the tooth punctures or tears through the foil and causes the torn edges to bend inwardly, i.e., into the tub of the receptacle.
  • the torn edges or flaps bend outwardly, or one edge or flap can go inwardly and the other outwardly.
  • the tooth With the penetration depth of the tooth maintained, the tooth can then be moved across the foil surface in any geometric pattern whereby a side leading edge of the tooth essentially separates the foil. In this embodiment the tooth is moved in an arc-shaped movement and for a desired arc-angle.
  • the arc- angle is typically at least about 90° or more, such as at least about 100°, 110°, 120°, 130°, 140°, 150°, 160°, 170°, or 180°, and may range from, e.g., from 40° to 350°, such as 50° to 300°, 60° to 250°, 70° to 200°, or 80° to 150°, or combinations of any of the foregoing.
  • preferred would be a complete 360° cut/tear, except that the central portion of the foil would come loose.
  • the goal is to make as long of a cut/tear as possible, with just enough to keep the lidstock from coming apart.
  • FIGS. 126-127 illustrate such tooth movement and FIG. 102 illustrates two arc-shaped inlet openings formed by two teeth of the type shown in FIGS. 126-127.
  • the tooth or teeth can be retracted or caused to move away from the package in a linear or curvilinear fashion.
  • This movement forms one or more arc-shaped inlet openings in the package or receptacle whereby the torn edges of the opening(s) are bent inwardly, i.e., into the receptacle, thereby ensuring that the edges will not substantially obstruct the flow of air into the receptacle when the receptacle is thereafter evacuated using the apparatus.
  • This puncturing system provides advantages over a cutter mechanism that descends into the foil, cuts openings in the foil and then stays in place during evacuation. In some embodiments of this puncturing system, the user is aware of rotation but is not aware of the telescoping of the cutter mechanism, which occurs internally.
  • one or more teeth creates one or more arc-shaped inlet openings in the foil using a plowing effect. As explained above, this creates a controlled tear of the foil and bends the cut or torn edges into the package.
  • the tooth is designed to penetrate and separate the foil in such a way that it produces a very smooth edge.
  • This edge has a Hausdorff dimension of no greater than 1.5, or no greater than 1.4, or no greater than 1.3, or no greater than 1.2, or no greater than 1.1.
  • the Hausdorff dimension is a way of measuring smoothness of an edge.
  • One or more embodiments of the devices described herein create edges in the foil or other sealing material which are smooth, thus less susceptible to tearing. Another advantage of this type of cutting/tearing is that it minimizes chances for loose foil or foil particulate to potentially break away and enter the drug path of the device and possibly enter the user's lungs.
  • the tooth essentially creates a consistent and precise tear (producing openings of substantially reproducible size and shape) in the foil, which also contributes to reducing the overall variability in the aerosol performance of the device. This also allows the opening(s) in the foil to play an active role in the effective evacuation of the blister or receptacle by allowing and/or directing the airflow into the drug package more efficiently.
  • FIGS. 124-127 illustrate a cutter mechanism having two teeth.
  • puncturing occurs first, followed by tearing, these actions can occur simultaneously.
  • a desired opening can be created by a single puncturing movement, producing a desired shape.
  • the puncturing and tearing can occur essentially simultaneously by a mechanism that lowers a leading edge into a material to be cut or torn while at the same time moving through a cutting or tearing arc.
  • the shape of the tooth at the plane where it cuts or tears through the material to be cut or torn is a balance of not too sharp (such that it cuts, not tears, but is subject to wear over time) and not too blunt (such that it creates an uncontrolled tear in the material to be cut or torn).
  • an elliptical leading edge of the tooth may have a rho value from 0.1 to 1.0, such as from 0.2 to 0.9, 0.3 to 0.8, or 0.4 to 0.7.
  • FIGS. 126-127 show a tooth shape having a rounded leading end for causing the tearing.
  • the tooth has two leading edges to allow bidirectional cutting or tearing.
  • the orientation of the tooth has been optimized.
  • the yaw of the tooth typically ranges from 0-12°, 4- 10°, 6-8°, away from center.
  • the yaw of the tooth is not critical, the finding that yaw is ideally 6-8° away from center is a surprising result. If the yaw is not within this ideal range, the tear tends to be more ruffled on one side.
  • the tooth is particularly useful in puncturing a drug package receptacle that has a foil-plastic laminate lid covering a tub that is roughly hemispherical in shape. Non-limiting examples of such receptacles are disclosed in U.S. Pat. No.
  • FIGS. 108-111 Other non-limiting examples of the receptacle are shown in FIGS. 108-111.
  • the top of the drug package is generally planar and is sealed with a foil lidstock over its top surface.
  • the drug package receptacle is inserted into the apparatus (see e.g., FIGS. 4 and 104-107), and the apparatus is manipulated to automatically open the drug package when a rotary motion is applied to two halves or housing parts of the apparatus (see, e.g., FIG. 5).
  • the actuation of the apparatus creates several holes in the foil lidstock (see, e.g., FIG. 102).
  • Air inlet openings are formed to allow ambient air to enter the drug package (e.g., the two arc-shaped openings in FIG. 102).
  • An exit opening is also formed to allow the drug-entrained air to exit the drug package (e.g., the central opening in FIG. 102).
  • tooth or teeth is/are used to cut or tear one or more arc-shaped air inlet openings by descending, e.g., rapidly, into the drug package, then moving through an arc, and then retracting completely out of the drug package. This movement takes place in the apparatus when the user rotates one housing part of the apparatus relative to another housing part.
  • FIG. 5 shows one non-limiting way in which this can occur.
  • the shape of the tooth can have several specific features that enhance its function.
  • the tip of the tooth(s) can be made to come to a point (see e.g., FIG. 124) to allow the tooth to efficiently pierce the foil as it descends into the drug package.
  • the body of the tooth can have a constant or substantially uniform cross section (see e.g., FIGS. 126-127) over the expected range of interaction with the foil.
  • the leading edge of the body of the tooth should preferably not be too sharp, so as to ensure that the edge will not wear unpredictably and possibly create debris.
  • the leading edge of the tooth should also have a specific bluntness (e.g., a rounded configuration such as is shown in FIGS.
  • the width of the body of the tooth can be designed to give the desired width of arc-shaped opening in the foil. Non- limiting size dimensions in millimeters and a shape for the tooth or teeth are shown in FIGS. 124-127.
  • the tooth shape is also designed to allow it to be molded from injection-moldable plastics.
  • a support member i.e., a member which supports the tooth
  • plastic can eliminate the need to separately affix and align the tooth or teeth in another member. This facilitates high volume manufacture.
  • the use of plastic and the ability to integrate the tooth or teeth into another part can also result in more consistent performance and lower cost for the apparatus.
  • the tooth shape also does not require any side pulls or other complications to the injection mold design. As such, the tool will require less maintenance over its lifetime.
  • Non-limiting examples of a support member or cutter mechanism having such teeth are shown in FIGS. 53-59 and 124-125.
  • the blade or cutter mechanism of the present invention can be used in any device that is configured to cut or tear a thin layer, sheet, or film, such as a foil.
  • the invention also contemplates utilizing the blade described herein on devices that include one or more features disclosed in WO2004/110539, WO03/086515, WO03/086516, WO03/086517, and U.S. Patent Application Publication Nos. 2005/0279356 and 2007/0068524, the disclosures of these documents are hereby expressly incorporated by reference in their entireties.
  • the cutter mechanism described herein (or portions thereof such as the tooth or teeth, e.g., plastic tooth or teeth) can be used in an inhaler described in WO 2004/110539.
  • the cutter mechanism of the invention (or portions thereof such as the tooth or teeth) can also be used in an inhaler described in WO 03/086515, and more specifically can be used in place of the foil cutter (ref. No. 11 in WO 03/086515), whereby the disclosed device uses aspects of the instant invention to open a receptacle containing a powder and having a foil lid, e.g., by tearing the foil.
  • the cutter mechanism described herein (or portions thereof such as the tooth or teeth, e.g., plastic tooth or teeth) can also be used in an inhaler described in WO 03/086516, and more specifically can be used in place of the foil cutter (ref. No.
  • the cutter mechanism described herein can be used in an inhaler described in US 2005/0279356, and more specifically can be used in place of the foil cutter disclosed in US 2005/0279356, whereby the disclosed device uses aspects of the instant invention to open a receptacle containing a powder and having a foil lid, e.g., by tearing the foil.
  • the cutter mechanism described herein can be used in an inhaler described in US 2007/0068524, and more specifically can be used in place of the foil cutter disclosed in US 2007/0068524, whereby the disclosed device uses aspects of the instant invention to open a receptacle containing a powder and having a foil lid, e.g., by tearing the foil.
  • the cutter mechanism described herein can be used in an inhaler of the type described in any of the following documents: US 6,360,744; US 6,422,236; US 6,436,227; US 6,526,969; US 6,881 ,398; US 6,868,853; US 6,840,239; US 6,622,723; and US 6,651 ,341 , the disclosures of these documents are hereby expressly incorporated by reference in their entireties.
  • the blade of the present invention may be used in a device for de-aggregating and into air dispersing particles of a finely divided dry medication powder loaded onto a substrate member.
  • the powder may be made available for inhalation by means of a dry powder inhaler comprising a nozzle with a nozzle outlet, a nozzle inlet, and a nozzle inlet aperture positioned adjacent to available powder.
  • a dry powder inhaler comprising a nozzle with a nozzle outlet, a nozzle inlet, and a nozzle inlet aperture positioned adjacent to available powder.
  • Suction of air when applied to the nozzle outlet, creates a local, high velocity air stream into the nozzle inlet aperture and out through the nozzle outlet.
  • a relative motion when introduced between the nozzle and powder onto the substrate member, is arranged such that the nozzle inlet, and the local, high velocity air stream going into the nozzle inlet aperture, traverses the available medication powder, wherein the powder is released and dispersed.
  • Particle aggregates within the finely divided medication powder are de-aggregated by being subjected to shearing stresses, inertia, and turbulence in the local, high velocity air stream going into the nozzle inlet aperture, whereby the particles of the finely divided medication powder are gradually dispersed into the air as available powder is gradually accessed by the local, high velocity air stream when the nozzle and the powder are moved in relation to each other.
  • the present invention is not limited to the above cutter mechanism. Other cutter mechanisms may be used with other features of the present invention, e.g., deoccluding device, trigger, orifice, etc.
  • cutter mechanism operations include: (1) punch and retract; (2) punch and stay in position during inhalation; and (3) punch, rotate, and stay in position during inhalation.
  • the cutter mechanism may be made of wire stock, or by metal injection molding, sheet metal stamping, or sheet metal stamping and grinding.
  • a deoccluding device which may be used in any application in which a deoccluding a tube is desired.
  • the deoccluding device is arranged within and/or is configured to clean a feed tube.
  • the feed tube can be a tube member which directs air flow from the exit opening of a receptacle toward an exit or mouthpiece opening of an inhalation apparatus.
  • such a device can particularly be utilized in the apparatus and/or method for aerosolizing a powdered medicament as described herein.
  • the receptacle can take the form of a primary drug package, which can be sealed against moisture using a foil that spans a tub containing the powder (e.g., of the type shown in FIGS. 108-111). To release the powder for inhalation by a user in an effective manner, this foil is preferably punctured with an opening in a substantially controlled fashion. This control can be performed effectively using the puncturing and deoccluding device arranged within the feed tube. [0209] In dry powder inhalers, there is a tendency for the flow paths (and especially any restrictions therein) to become clogged with powder, particularly in humid conditions.
  • the deoccluding device can thus be configured to actively deocclude the feed tube upon each actuation of the apparatus to ensure the drug path, i.e., the path for the aerosolized powdered medicament, remains unclogged. In some embodiments, the deoccluding device deoccludes by contacting the feed tube.
  • the deoccluding device deoccludes by riding just over the surface of the feed tube, such as at a sufficient distance to prevent or limit clogging while avoiding contact with the surface or minimizing contact with the surface, e.g., at a distance within 0.2 mm, such as within 0.15 mm or within 0.1 mm. By avoiding contact, less friction results, and the device typically operates more smoothly.
  • the deoccluding device can also create an exit hole or opening in the receptacle (see e.g., the center exit opening in FIG. 102), thereby eliminating potential misalignments of the exit hole in the receptacle, e.g., blister pack, with the drug exit tube in the apparatus.
  • the deoccluding device provides active deocclusion of the drug path upon each actuation of the apparatus (e.g., each time the apparatus is actuated as shown in FIG. 5).
  • this device increases the useful life of the apparatus.
  • the useful life may range from 50 to 400 uses, such as 70 to 200 uses, 80 to 150 uses, or 90 to 110 uses.
  • FIG. 112 shows air/powder flow up through a feed tube from the receptacle after the deoccluding device has cleaned the inside of the feed tube and assumed a retracted position.
  • the invention provides significant advantages over conventional inhalation devices. For example, certain inhalation devices are susceptible to clogging and gradually decline in performance over time.
  • the deoccluding device can also provide the additional function of opening the exit hole (see, e.g., center opening in FIG. 102) in the primary drug package, thereby ensuring its concentricity with the drug exit tube. In this case, the device can therefore be characterized as a puncturing and deoccluding device. Since concentricity of the hole relative to the tube increases the efficiency of the coupling between the drug package and the apparatus, the deoccluding device functions to maintain this concentricity.
  • the deoccluding device may be a wireform, e.g., metal wireform, such as a stainless steel wireform.
  • a wireform e.g., metal wireform, such as a stainless steel wireform.
  • the device can provide multiple functions while also ensuring that the total part count of the apparatus is minimized. This results in a corresponding reduction in the cost of the apparatus.
  • the deoccluding device could also be a molded member, such molded plastic, and can even be formed as a one-piece member with one of the components of the apparatus (or features of the components) such as, e.g., the feed tube or either a cutter mechanism (e.g., of the type shown in FIGS. 53-59 and 124-125) or a lower bearing member (e.g., of the type shown in FIGS. 66-72). .
  • the deoccluding device is simple in design and can have the form of a single generally U-shaped or generally V-shaped (or a combination thereof) wireform part.
  • the puncturing and deoccluding device can have the configuration shown in FIGS. 51-52.
  • the device can also be configured to rotate at least partially upon actuation of the apparatus. This at least partial rotation of the apparatus (or parts thereof) can serve to drive the device (or cause its movement) without requiring a user to perform any other steps.
  • the device can thus be driven internally and is therefore not dependent on the speed or technique of actuation by the user.
  • the mechanism itself can be as simple as a thin wire, so it does not provide any significant impediment to the flow through the apparatus.
  • the device is not limited to a wire (or round wire) and can have a number of cross-sectional shapes such as round, oval, square, polygonal, etc., provided the device is capable of providing one or more of the advantages noted herein.
  • the device is at least configured to be able to provide active deocclusion of at least a portion of the drug path upon each actuation of the apparatus.
  • the receptacle can be, by way of non-limiting example, a drug package that utilizes a foil-plastic laminate lid and a tub that is roughly hemispherical in shape.
  • FIGS. 108-111 show non-limiting examples of such receptacles.
  • the top of the drug package can be planar, and the tub is sealed with a foil lidstock over its entire top surface.
  • Such a drug package can be inserted into an apparatus (see e.g., FIG. 4) containing the deoccluding device and the apparatus can be manipulated to automatically cause an opening of the drug package when, e.g., a rotary motion is applied to two portions of the apparatus (see e.g., FIG. 5).
  • FIG. 102 shows a lidstock having two arc-shaped inlet openings and a center exit opening formed by a puncturing and deoccluding device of the type described herein.
  • the deoccluding device can have the form of a wire loop that is configured to rotate, e.g., about 180°, with each actuation of the apparatus.
  • FIG. 5 shows one non-limiting way in which the actuation movement can occur.
  • the deoccluding device can also be configured to descend (e.g., move linearly and/or axially within the feed tube toward the lidstock) and retract (e.g., move axially away from the lidstock) by, e.g., about 2 mm, either during or after it initially experiences rotary motion.
  • the vertical sides of the wire loop are configured to deocclude an inside of the feed tube while the bent end, e.g., curved end, perforates the center of the receptacle, e.g., blister pack or drug package.
  • the initial penetration of the receptacle e.g., drug package or blister pack
  • the circular hole may be formed by an initial piercing followed by plowing.
  • the feed tube does not move relative to the blister pack, so that it can serve as a guide for the movement of the wire loop. This ensures concentricity (i.e., axial alignment) of the hole in the lidstock relative to the feed tube.
  • the controlled relative motion of the wire loop and the blister/feed tube is able to provide both the deocclusion and blister opening functions.
  • the deoccluding device can be used to clean the inside of the feed tube of the lower bearing member shown in FIGS. 66-72 and having upper and lower ends 10On and 100s, respectively.
  • the wire diameter can be sized to properly form the hole or opening in the receptacle and also perform the deocclusion function efficiently without significantly obstructing air flow through the device when retracted.
  • the wire should not be made too small in diameter so as not to propagate an uncontrolled tear in the lidstock and should not be made too large so as to obstruct the airflow through the feed tube.
  • the wire may have a diameter ranging from 0.020 inch to 0.054 inch, such as 0.022 inch to 0.044 inch or 0.024 inch to 0.034 inch.
  • the diameter of the wire affects the radius of the bend possible. Typically, the ratio of the radius of the bend to the radius of the wire is 1.5 or less.
  • FIG. 112 shows flow through the feed tube with the deoccluding member in a retracted position. Impacting or Receptacle Impacting Device
  • the impacting device of the present invention can be used in most any application in which an impact is desired.
  • the impacting device may be used to impact receptacles inline during a filling process to break up powders.
  • such a device can particularly be utilized in the apparatus and/or method for aerosolizing a powdered medicament as described herein.
  • Non-limiting examples of such inhalation devices are shown in FIGS. 1-9, 24-27, and 128-138.
  • the receptacle can take the form of a primary drug package, which is sealed against moisture using a foil that spans the tub containing the powder (e.g., of the type shown in FIGS.
  • the impacting device has particular application in causing the powder arranged within the receptacle to be broken up into a more dispersible powder. It has been found that the powder in the blister pack receptacle is more easily deagglomerated if the blister pack is given a sharp impact before the blister pack is opened. Based on studies with an offline impact mechanism, the energy of impact typically ranges from 0.017 to 0.025 J, such as 0.007 to 0.085 J, or anything above about 0.005 J.
  • the device described herein is structured and arranged to provide such an impact to the blister pack. When such an impacting device is utilized on the apparatus described herein, the impact can occur upon insertion of the receptacle into the apparatus.
  • the impacting device when used on an inhalation apparatus, such as on the apparatus described herein, can be compact and can be made with only two additional components to the apparatus part count, that is, a torsion spring and an impacting member.
  • the invention also contemplates using a single member which includes or performs the functions of these devices.
  • the level of impact on the blister pack can be tailored to provide the maximum effect. For example, the impact should not be too light; otherwise it may not have the desired effect. It should also not be too heavy because it can cause the powder to compact on, among other places, an opposite surface of the blister pack from the location of impact.
  • the impacting device can be made of injection molded plastics compatible with high volume manufacturing.
  • the device can also made so as to be easily assembled in an apparatus, e.g., it can be assembled in the vertical axis, i.e., uniaxial assembly, (which is compatible with high volume automated assembly) and can be made so as to not require special adjustment.
  • the device can also desirably be configured so as to not require resetting by the user.
  • the impacting device is configured so that it can begin and end its movement in an apparent identical state. Because it can be configured to automatically reset so as not to require resetting by the user, the device will be less likely to accidentally end up in the wrong state (i.e., not reset).
  • the impacting device is preferably made so as to be simple and easy to assemble.
  • the receptacle can be configured to provide an impact to the receptacle upon its insertion into an apparatus.
  • This action can simultaneously provide feedback (i.e., the user can come to recognize the sound of a fully and properly inserted receptacle based on the noise generated by the impacting device) to the user of correct blister insertion.
  • the act of inserting the blister pack can also be utilized to provide the motive force for the activating the device.
  • a spring biasing the device can be lightly stressed when the device is not in use. A non-limiting example of such a spring is shown in FIG. 94.
  • the impacting device can be made entirely from one or more injection molded plastics. The travel of the blister pack into the apparatus (see, e.g., FIGS.
  • the impacting device can be a tri- lobed wheel with a central axle protruding out on one or more sides.
  • Non- limiting examples of such a tri-lobed wheel are shown in FIGS. 88-92.
  • the wheel When installed in an apparatus, the wheel can be constrained axially by ribs (e.g., ribs 16Oe in FIGS. 95-98) that protrude from a bottom surface of the apparatus or a portion thereof. Slots in these ribs can constrain or limit the overall movement of the axle of the wheel and also allow it to ride up and down vertically. In this arrangement, the wheel can be free to rotate and also move up and down in the slots.
  • FIG. 19 shows one non-limiting way in which the wheel can be mounted to the slots of the ribs and biased upwards by a spring.
  • Two lobes of the wheel can also be configured to rest against a horizontal surface that is in the same plane as the top of the blister pack insertion slot in the apparatus. Viewed from the side, the wheel can appear to generally form a "Y" shape (see, e.g., FIG. 104).
  • a leading edge of blister pack can contact one of the lobes of the wheel and cause the wheel to rotate (see, e.g., FIGS. 105-107).
  • each lobe of the wheel can have a notch at the end which catches the leading edge of the blister pack as it is inserted into the apparatus (see, e.g., FIG. 115).
  • each lobe of the wheel can be configured to contact the curved front portion of the tub of the receptacle as it is inserted into the apparatus (see, e.g., FIG. 104). Regardless, further sliding into the apparatus of the blister pack causes the wheel to rotate (see FIGS. 105-107 and 116-119). As the wheel rotates, the end of the contacted lobe moves with the blister pack or receptacle and along the horizontal surface above the blister insertion slot.
  • the wheel is biased upwards by the spring (e.g., a spring of the type shown in FIG. 94).
  • the spring e.g., a spring of the type shown in FIG. 94.
  • the wheel is caused to move downward or away from the horizontal surface. This movement is guided because the axle is movably disposed in the retention slots.
  • the spring becomes compressed.
  • the maximum compression of the spring occurs when the tri-lobed wheel resembles a generally upside-down "Y" as viewed from the side (see e.g., FIGS. 106 and 116).
  • this position can correspond to approximately 50%, such as 40% to 60%, blister insertion, i.e., the wheel will resemble the upside-down "Y" when the blister pack is inserted into the apparatus half-way.
  • the spring when the device is at rest, or during inhalation, the spring is compressed to 11.35 mm. When the device is cutting or tearing, the spring is compressed to 13.85 mm.
  • the free length of the spring is nominally 19.05 mm and the spring rate is 1.89 N/mm. This means that the nominal spring force is 14.5 N when at rest, and 9.8 N during cutting or tearing.
  • the spring force at rest typically ranges from 10 N to 16 N, such as 11 N to 15 N, or 12 N to 14 N.
  • the spring force during cutting or tearing typically ranges from 7 N to 11 N, such as from 8 N to 10 N.
  • the impacting device is also preferably configured so as not to interfere with the removal of the receptacle from the apparatus (see e.g., FIG. 7).
  • a tri-lobed wheel By utilizing a tri-lobed wheel, removal of the blister pack can occur easily. This is because the tri-lobed wheel does not need to rotate in an opposite direction very much to allow the tub to slide past.
  • the device can end up in a position which resembles the initial starting position, even though the wheel has turned 120° each time a receptacle is inserted. In this configuration, the impacting device ensures that no resetting of the apparatus by the user is needed, and the impacting device remains always ready for the insertion of another or new receptacle.
  • impact mechanisms include bistable springform, spring loaded mousetrap type mechanism, and embossed ridges on the blister to induce vibration.
  • Lock System or Receptacle Lock System
  • the lock system may be used in most any application in which a locking is desired.
  • the lock system may be a receptacle lock system in which an inhaler device is locked during insertion of a receptacle.
  • an inhaler device is locked during insertion of a receptacle.
  • One advantage of this device is that it prevents possible damage to the teeth of the receptacle puncturing mechanism which could otherwise occur if the teeth descend into portions of the receptacle which are more rigid and/or thicker instead of into the foil lid stock of the receptacle (which they are configured to penetrate and tear).
  • such device can be configured to allow only one predetermined shape of receptacle, e.g., blister pack.
  • such a device can particularly be utilized in the apparatus and/or method for aerosolizing a powdered medicament as described herein.
  • inhalation devices are shown in FIGS. 1-9, 24-27, 114-123 and 128-138.
  • the receptacle can preferably take the form of a primary drug package which is sealed against moisture using a foil that spans the tub containing the powder (e.g., of the type shown in FIGS. 108-111).
  • the device has particular application when used in the apparatus and/or method for aerosolizing a powdered medicament which utilizes single-use receptacles, e.g., blister packs.
  • the receptacle lock system can be configured to prevent relative rotation between two portions of an apparatus unless a receptacle of predetermined configuration is properly inserted into the apparatus. This feature increases the likelihood that the patient will be successfully dosed.
  • the receptacle lock system can also preferably allow relative rotation between two portions of an apparatus when a receptacle is not inserted into the apparatus. This can allow the user to become familiar with the operation of the apparatus without wasting a receptacle. It is also contemplated that the receptacle lock system may prevent relative rotation between two portions of an apparatus unless a receptacle of predetermined configuration is properly and/or fully inserted into the apparatus.
  • the lock device can function as follows: while the blister pack is inserted into the apparatus (see, e.g., FIG. 4), spring-loaded arms with interlock pins of the receptacle lock device can spread apart by angled edges of the blister pack. While these arms are spread apart and before they are moved to an original position, the lock device can prevent use and/or activation of the apparatus, i.e., it can prevent the type of movement shown in FIG. 5.
  • the lock device can prevent relative rotation of the parts of the apparatus such as the rotation of a mouthpiece relative to another housing part.
  • the interlock pins engage with one or more recesses, e.g., cutouts 17Og of FIGS. 108-111 , on the sides of the receptacle.
  • the arms move to an unlocked position, which will allow the user to activate or use the apparatus, e.g., the mouthpiece is then allowed to rotate relative to the lower half of the apparatus (see e.g., FIG. 5).
  • the lock device can have the configuration shown in FIGS. 84-87.
  • the receptacle includes a lower foil laminate comprising a blister for holding powder and an upper foil laminate covering the lower foil laminate.
  • the receptacle comprises a rear portion having three perpendicular sides, a middle portion comprising notches, and a tapered front portion. The notches are capable of interacting with the above- described receptacle interlock system.
  • Non-limiting examples of receptacle materials include those disclosed in U.S. Patent Nos. 5,589,275 and 6,270,869, which are incorporated herein by reference. Suitable foils are commercially available, e.g., from Alcan Inc. (Montreal, Quebec).
  • the invention also contemplates an arrangement wherein the receptacle is supported in a mechanism for advancing a continuous web (e.g., a strip or disk), which carries a plurality of receptacles past the fluidization location.
  • a continuous web e.g., a strip or disk
  • Still another aspect of the invention relates to triggers or trigger valves.
  • the trigger may be positioned between the receptacle and the outlet of the mouthpiece such that air flow from the receptacle to the outlet passes through the valve.
  • a non-limiting example of the trigger is shown in FIGS. 44- 47.
  • the trigger One function of the trigger is to ensure consistent and uniform dosing.
  • a threshold vacuum pressure To open the trigger, a threshold vacuum pressure must be applied.
  • the threshold vacuum pressure is usually at least about 15 cm H 2 O or at least 25 cm H 2 O, and typically ranges from 10 cm H 2 O to 50 cm H 2 O, such as from 15 cm H 2 O to 40 cm H 2 O, 18 cm H 2 O to 30 cm H 2 O, or 24 to 30 cm H 2 O.
  • the initial flow rate through the device is consistent with respect to intrapatient and interpatient variability.
  • the trigger functions to regulate air flow through the device.
  • the trigger also provides audible and tactile feedback to the user indicating correct inhalation.
  • Another function of the trigger is to deagglomerate the powder. Deagglomeration of the powder increases the fine particle fraction and increases the amount deposited in the lungs.
  • Still another function of the trigger is to reduce patient blowback. Reducing patient blowback increases the cleanliness of the device.
  • the trigger is typically automatically closing or self-closing, which eliminates the need for resetting the trigger. When the vaccum is removed, i.e., when the patient stops inhaling, the trigger is biased back into its original position. The valve will usually reset at valve pressure drop below 5 cm H2O, such as less than 4 cm H 2 O or less than 3 cm H 2 O.
  • the trigger is also self-deoccluding.
  • the opening and closing of the trigger prevents powder from accumulating thereon.
  • the Shore A hardness of the trigger usually ranges from 20 to 60, such as 30 to 50 or 35 to 45.
  • Non-limiting examples of valves include those disclosed in U.S. Patent Nos. 5,213,236; 5,377,877; 5,409,144; 5,531 ,363; 5,839,614; 6,065,642; 6,079,594; 6,273,296; 6,405,901 ; 6,951 ,295; and 7,086,572; and U.S. Published Application No. 2004/0000309, which are incorporated herein by reference.
  • Suitable valves are commercially available, e.g., from Liquid Molding Systems (Midland, Ml), and many of these valves are described on their website at www.siliconelms.com, which is incorporated herein by reference.
  • the invention contemplates using one or more of the above-noted features, e.g., the cutter mechanism, the deoccluding device, the receptacle impacting device, the receptacle lock device or system, the receptacles, and the trigger, in or on devices such as apparatuses for aerosolizing a powdered medicament, such features can also be used alone, in various apparatuses, and in an apparatus of the type described herein.
  • the cutter mechanism could be used for cutting different materials.
  • the invention also relates to the pulmonary delivery of dry powder medicament such that an arrangement for efficient and repeatable powder fluidization and deagglomeration is combined with an arrangement for providing, through airflow control, enhanced consistency of lung deposition within an apparatus powered by the user's inhalation effort.
  • a passive DPI dry powder inhaler
  • a passive DPI is a man-machine system including the powder to be delivered via pulmonary route, a delivery device (i.e., an apparatus of the type described herein), and the user. The user, who supplies power for the device through inhalation effort, tends to be the source of highest variability.
  • One aim of the delivery apparatus is to aerosolize the powder medicament consistently in both size of dose delivered and aerosol quality.
  • Powder quality may be measured as fine particle fraction, or FPF, to indicate the fraction of the aerosolized powder having particle size below a given threshold.
  • FPF fine particle fraction
  • the primary particle size is substantially smaller than the threshold used for FPF. Therefore, FPF is most often a function of agglomeration state, or percentage distribution of particles that are single primary particles or agglomerations of multiple primary particles.
  • the first such stage of aerosolization is Powder Fluidization that is intended to produce a suspension of particles of powder medicament in an air stream.
  • FPF and agglomeration state of the powder medicament are not ideal after Powder Fluidization. Therefore, a second stage may be utilized and is designated here as Powder Deagglomeration.
  • the Powder Deagglomeration stage can provide a way to break-up a high percentage of agglomerates into smaller agglomerates or possibly into primary particles.
  • the Powder Deagglomeration may be accomplished through shearing airflows, turbulent airflows, impaction, or accelerating flows.
  • Efficacy of two-stage powder aerosolization depends in part on inhalation flow patterns. For instance, it has been found that high value of flow increase rate, or FIR, is desirable in accomplishing the Powder Fluidization phase. For instance, the peak FIR often exceeds 5 liters/sec 2 , such as above 10 liters/sec 2 .
  • the peak FIR may, e.g., range from 10 liters/sec 2 to 50 liters/sec 2 , such as 15 liters/sec 2 to 40 liters/sec 2 or 20 liters/sec 2 to 30 liters/sec 2 .
  • the inhalation control function can be a single stage or can be divided into two stages.
  • the first stage of inhalation control can provide a way for imposing a threshold pressure differential, such that the user must meet or exceed this threshold pressure differential through vacuum of inhalation effort before flow begins.
  • the threshold vacuum may be accomplished with a trigger valve (e.g., of the type shown in FIGS. 44-47), i.e., a mechanism for enforcing threshold pressure differential such that essentially no airflow can occur until pressure drop across the trigger valve exceeds the threshold pressure differential.
  • the optional second stage of inhalation control can provide a way for regulating flow rate once the threshold vacuum is achieved, wherein the regulating arrangement may be a flow regulator valve that changes orifice shape in order to control flow rate as a predetermined function of pressure drop across the flow regulator valve.
  • an apparatus for aerosolizing a powdered medicament which is a passive dry powder inhaler.
  • a passive dry powder inhaler Non-limiting examples of such devices are shown in FIGS. 1- 9, 24-27, and 128-138.
  • the term passive means that it requires patient inspiratory effort to generate an aerosol, in contrast to an active inhaler which utilizes a mechanism in the apparatus to create the aerosol.
  • the drug product is packaged in a receptacle, e.g., foil blister pack, which is opened by the device and evacuated using the user's, e.g., a patient's, breath.
  • FIGS. 108-111 show non-limiting example of such a receptacle, which happens to be a foil blister pack.
  • the apparatus can utilize two main modules or component assemblies, i.e., a receptacle preparation module and an aerosolization module.
  • the receptacle preparation module can utilize, among other things, one or more of a receptacle impact device of the type described above, a receptacle lock device of the type described above, a receptacle as described above, a trigger as described above, a blister centering arrangement, a deoccluding device of the type described above, and a receptacle puncturing mechanism of the type described above.
  • Receptacle preparation may be achieved by inserting a receptacle or blister pack Q into the apparatus (e.g., as is shown in FIGS. 4, 104-107, and 115-119) and until a click is heard, indicating that the receptacle impact device N has actuated. While the blister pack Q is being inserted, the spring-loaded interlock pins of the receptacle lock device M are caused to spread apart, preventing the mouthpiece B of the apparatus from being rotated prematurely. When the blister pack Q has reached the fully inserted or home position (see e.g., FIGS. 107 and 119), the interlock pins 130a (see FIGS. 84-87) engage with cutouts 17Og (see FIGS.
  • the receptacle impact device N can be a three-lobed cam wheel (see FIGS. 88-92) that is spring-loaded via spring O (see FIG. 94). As the blister pack Q is pushed into the apparatus (see FIG. 4), this mechanism N stores energy via the spring O, which is then released to create a sudden impact on the blister tub. This acts to loosen the powder in the receptacle Q to thereby improve blister pack evacuation efficiency and reduce variability in emitted dose.
  • the emitted dose of the present invention is typically at least 60%, such as at least 70%, at least 75%, at least 80%, at least 85%, or at least 90%.
  • the standard deviation of the emitted dose is typically less than 10%, such as less than 7%, less than 5%, or less than 3%.
  • the emitted dose may range from 60% to 90% with an RSD of 3% to 10%.
  • the blister centering arrangement which can utilize, among other things, curved support surface 110h of the body member K shown in FIGS. 73-78, can serve to align the center of the blister tub with the central feed tube in the apparatus.
  • the puncturing portion 7Og (see FIGS. 51-52) of the deoccluding device G plunges into the foil lid stock on the top of the blister pack Q to create an exit opening.
  • the puncturing teeth 8Ot (see FIGS.
  • the receptacle puncturing mechanism H are positioned such that they descend into the foil lid shortly after the puncturing portion 7Og of the deoccluding device G. This occurs because the puncturing end 7Og of the deoccluding device G is position below the teeth 8Ot of the receptacle puncturing mechanism H. The puncturing end 7Og of the deoccluding device G thus contacts and punctures the lid of receptacle Q just before the teeth 8Ot of the receptacle puncturing mechanism H. As the mouthpiece B is rotated (see FIG.
  • the puncturing portion 7Og of the deoccluding device G displaces foil to create a center outlet hole while the teeth 8Ot of the receptacle puncturing mechanism H form two approximately 120° arc-shaped inlet openings.
  • FIG. 102 shows the top of a receptacle with two inlet openings and a central exit opening formed in this way. The inlet openings form an inlet for air through the blister pack Q and the outlet opening allows air and powder to exit from the receptacle Q.
  • FIG. 112 illustrates one non-limiting way in which this flow can take place.
  • the teeth 8Ot preferably do not actually cut the openings in the foil lid, and instead preferably cause or propagate a controlled tear(s).
  • the teeth 8Ot do not have sharp side leading edges and instead have rounded (or more blunted) leading edges to facilitate controlled and consistent propagation of the inlet openings.
  • FIGS. 126-127 illustrate one non-limiting rounded configuration for the leading edge of the teeth 8Ot.
  • the apparatus is ready for aerosolization of the powder in the blister pack.
  • the user places the mouthpiece B, and more specifically the upper portion thereof, between his or her lips and creates a seal.
  • the mouthpiece B shape can preferably be designed to be optimal for a wide range of mouth sizes and user preferences.
  • a trigger mechanism E located in the apparatus opens.
  • FIG. 99 shows a trigger E in the open position
  • FIGS. 25-27 show the trigger E in both the open position and the closed position.
  • the trigger mechanism E can, by way of non-limiting example, have four petals which open when a movable portion of the trigger is inverted. Although four petals is most preferred, anywhere from 3 to 6 petals is reasonable.
  • the petals may also include other shapes, such as slits that branch off at the ends in the form of a cross fourchee.
  • the trigger E opens, outside air is allowed to flow through the apparatus and, in particular, through two primary paths.
  • the first path is through the blister itself, with air coming into the two, e.g., 120°, arc-shaped openings and out through the center hole and into the feed tube (see FIG. 112).
  • This air draws in the fluidized powder from the blister pack Q.
  • the flow then goes up through the feed tube, through an orifice (e.g., through center opening of member F) and the trigger E and into the user's lungs.
  • the larger particles are further deagglomerated to create a fine aerosol suitable for deposition in the deep lung.
  • positioning the trigger E between the receptacle and the user results in deagglomeration of powder that would not occur if the trigger E were placed upstream of the receptacle. If the trigger E were placed upstream of the receptacle, the resistance of the trigger E would not deagglomerate powder.
  • the second path is for bypass air which is designed to reduce the overall resistance of the apparatus and to improve user comfort.
  • the overall resistance of the apparatus is usually less than 0.20 (cm H2O) y 7liter/minute, such as less than 0.15 (cm H2O) 1/2 /liter/minute, or less than 0.10 (cm H2O) y 7liter/minute, at a flow rate of 40 Lpm, and typically ranges from 0.15 to 0.21 (cm H2O) y 7liter/minute, such as 0.16 to 0.20 (cm H2O) y 7liter/minute or 0.17 to 0.19 (cm H2O) y 7liter/minute at a flow rate of 40 Lpm.
  • the bypass air enters the apparatus and passes through a plurality of holes 8Oe (see FIGS. 53-59), in the receptacle puncturing mechanism H and also serves to focus the central flow of aerosol.
  • the number of holes may range from 2 to 10, such as 3 to 9, 4 to 8, or 5 to 7.
  • the hole diameter typically ranges from 0.9 mm to 2.0 mm, such as from 0.9 mm to 1.4 mm, or 1.0 mm to 1.3 mm.
  • the holes need not be round, although round holes are relatively easy to manufacture and fine tune.
  • FIG. 113 illustrates one non-limiting way in which two flow paths can occur in the apparatus.
  • the apparatus can utilize a flow rate of approximately 30 liters per minute.
  • the air flow through the receptacle Q can be approximately 40% while the bypass air flow is approximately 60%. This helps prevent powder deposition within the apparatus, and particularly, between the cutter mechanism H and the outlet of the mouthpiece B.
  • the flow through the receptacle ranges from 30% to 50%, such as 35% to 45%, depending on the overall resistance of the device, receptacle size, and receptacle opening size.
  • the bypass airflow typically ranges from 50% to 70%, such as 55% to 75%, of the total flow.
  • the apparatus is configured so that leak paths are minimized and/or optimized to provide acceptable or optimal performance of the apparatus.
  • Key contributors to aerosol performance are the ratio of blister flow to total flow (e.g., controlled by the size of the bypass holes 8Oe in the receptacle puncturing mechanism H), the size of the orifice 6Oj (see FIGS. 48- 50), and the length of the slits 50c and 5Od (see FIGS. 58-67) of the trigger E.
  • blister/total flow ratios can be between 20% to 70%, such as from 25% to 65%, 30% to 60%, or 35% to 55%, and orifice 6Oj sizes or diameter can be between 3 mm and 13 mm, such as between 4 mm and 12 mm, or 5 mm and 11 mm.
  • trigger slit length (determined by the smallest diameter circle which fully encloses or encircles the generally X-shaped slits 50c and 5Od) can range from 0.2 inches to 0.6 inches, such as 0.3 inches to 0.5 inches, and can be approximately 0.34 inches. In this regard, the trigger slit length typically ranges from 50% to 80%, such as 60% to 70%, of the diameter of the active (non-clamped) portion of the trigger.
  • the trigger E One function of the trigger E is to ensure consistent and uniform dosing. In this regard, assuming the trigger E opens, the trigger E opens at generally the same threshold vacuum pressure regardless of the user or user's effort. Once the trigger E opens, the flow rate through the device typically reaches its peak within 20 ms, e.g., within 15 ms or within 10 ms. [0255] The trigger E is typically self-closing, which eliminates the need for resetting the trigger E. When the vacuum is removed, i.e., when the patient stops inhaling, the trigger E is biased back into its original position. [0256] Typically, the trigger E is also self-deoccluding. The opening and closing of the trigger E prevents powder from accumulating thereon.
  • the deoccluding device G also serves to clean the feed tube FT (see FIGS. 66-72) with each use. This functions as follows: with each rotation (e.g., 180 degree rotation) of the mouthpiece B, the deoccluding device G deoccludes the inside of the feed tube FT, thereby minimizing the amount of powder left on the inner surface. This prevents long-term buildup on the feed tube FT and extends the life of the apparatus.
  • the feed tube FT does not enter the receptacle Q.
  • the access surface can be pierced simultaneously with the insertion or engagement with the feed tube FT.
  • the feed tube FT can be made to not have jets or ejector tubes within the flow path, and the clear, undisrupted flow path can thereby reduce any tendency for the feed tube FT to clog or otherwise lose dispersion efficiency.
  • the invention provides for a breath-actuated dry powder inhaler which can generally be used for any dry powder, e.g., dry powder insulin.
  • the apparatus may be used with the dry powder described in U.S. Provisional Application No. 61/000,543, filed October 25, 2007, which is incorporated herein by reference.
  • the apparatus may be used, e.g., with a dry powder pharmaceutical composition comprising, in percent by weight: from about 60% to about 95% insulin; and from about 5% to about 30% buffer; wherein when the composition is dissolved at a concentration of 1 mg/ml in distilled water to form a solution, the solution has a pH greater than or equal to 7.5.
  • the dry powder may include an active agent.
  • the active agent described herein includes an agent, drug, compound, composition of matter, or mixture thereof, which provides some pharmacologic, often beneficial, effect. This includes foods, food supplements, nutrients, drugs, vaccines, vitamins, and other beneficial agents. As used herein, the terms further include any physiologically or pharmacologically active substance that produces a localized or systemic effect in a patient.
  • An active agent for incorporation in the pharmaceutical formulation described herein may be an inorganic or an organic compound, including, without limitation, drugs which act on: the peripheral nerves, adrenergic receptors, cholinergic receptors, the skeletal muscles, the cardiovascular system, smooth muscles, the blood circulatory system, synoptic sites, neuroeffector junctional sites, endocrine and hormone systems, the immunological system, the reproductive system, the skeletal system, autacoid systems, the alimentary and excretory systems, the histamine system, and the central nervous system.
  • drugs which act on: the peripheral nerves, adrenergic receptors, cholinergic receptors, the skeletal muscles, the cardiovascular system, smooth muscles, the blood circulatory system, synoptic sites, neuroeffector junctional sites, endocrine and hormone systems, the immunological system, the reproductive system, the skeletal system, autacoid systems, the alimentary and excretory systems, the histamine system, and the central nervous system.
  • Suitable active agents may be selected from, for example, antidepressants, hypnotics and sedatives, psychic energizers, tranquilizers, respiratory drugs, anticonvulsants, muscle relaxants, antiparkinson agents (dopamine antagnonists), analgesics, antiinflammatories, antianxiety drugs (anxiolytics), appetite suppressants, antimigraine agents, muscle contractants, anti-infectives (antibiotics, antivirals, antifungals, vaccines) antiarthritics, antimalarials, antiemetics, anepileptics, angiotensin Il receptor blockers, epithelium sodium channel blockers, bronchodilators, cytokines, growth factors, anti-cancer agents, antithrombotic agents, antihypertensives, cardiovascular drugs, antiarrhythmics, antioxicants, anti-asthma agents, hormonal agents including contraceptives, sympathomimetics, diuretics, lipid regulating agents, antiandr
  • the active agent may fall into one of a number of structural classes, including but not limited to small molecules, peptides, polypeptides, proteins, polysaccharides, steroids, proteins capable of eliciting physiological effects, nucleotides, oligonucleotides, polynucleotides, fats, electrolytes, and the like.
  • active agents suitable for use in this invention include but are not limited to one or more of calcitonin, amphotericin B, erythropoietin (EPO) 1 Factor VIM, Factor IX, ceredase, cerezyme, cyclosporin, granulocyte colony stimulating factor (GCSF), thrombopoietin (TPO), alpha-1 proteinase inhibitor, elcatonin, granulocyte macrophage colony stimulating factor (GMCSF), growth hormone, human growth hormone (HGH), growth hormone releasing hormone (GHRH), heparin, low molecular weight heparin (LMWH), interferon alpha, interferon beta, interferon gamma, interleukin-1 receptor, interleukin-2, interleukin-2 fusion protein, interleukin-1 receptor antagonist, interleukin-3, interleukin-4, interleukin-6, interleukin-11 , luteinizing hormone releasing hormone (LHRH), insulin,
  • Patent No. 5,922,675 which is incorporated herein by reference in its entirety
  • amylin, C-peptide, somatostatin, somatostatin analogs including octreotide, vasopressin, follicle stimulating hormone (FSH), insulin-like growth factor (IGF), insulin-like growth factor binding protein (e.g., IGFBP3), insulintropin, macrophage colony stimulating factor (M-CSF), nerve growth factor (NGF), tissue growth factors, keratinocyte growth factor (KGF), glial growth factor (GGF), tumor necrosis factor (TNF), endothelial growth factors, parathyroid hormone (PTH), glucagon-like peptide thymosin alpha 1 , llb/llla inhibitor, alpha-1 antitrypsin, phosphodiesterase (PDE) compounds, VLA-4 inhibitors, bisphosponates, respiratory syncytial virus antibody, cystic fibrosis transmembrane regulator (CFTR) gene
  • meperidine prednicarbate, glyburide, ergocalciferol, methanamine, hydrocortisone, betaxolol, furosemide, indapamide, ambenonium, nilutamide, metronidazole, desipramine, hydroxychloroquine, rifapentine, milrinone, diflorasone, rifampin, tiludronate, pentazocine, pentoxyifylline, hyaluronic acid, benzalkonium, tissue-plasminogen activator, CMV immune globulin, glucocerebrocidase, trimetrexate, porfimer, sterile thiotepa, amifostine, doxorubicin, 3TC 1 daunorubicin, cidofovir, carmustine, mitoxantrone, HIV protease inhibitor, dopamine DA1 agonist, carbamazepine, ser
  • Active agents for use in the invention further include nucleic acids, as bare nucleic acid molecules, RNAi, aptamers, siRNA, vectors, associated viral particles, plasmid DNA or RNA or other nucleic acid constructions of a type suitable for transfection or transformation of cells, i.e., suitable for gene therapy including antisense, and stem cells.
  • an active agent may comprise live attenuated or killed viruses suitable for use as vaccines, such as cytomegalovirus, rabies, HIV, S.
  • the active agent may also comprise antibodies, such as monoclonal antibody or monoclonal arntibody ⁇ fragment, such as anti-CD3 mAb, digoxin-binding ovine antibody fragment, anti-RSV Ab, anti-TAC mAb, or anti-platelet mAb.
  • antibodies such as monoclonal antibody or monoclonal arntibody ⁇ fragment, such as anti-CD3 mAb, digoxin-binding ovine antibody fragment, anti-RSV Ab, anti-TAC mAb, or anti-platelet mAb.
  • Other useful drugs include those listed within the Physician's Desk Reference (most recent edition).
  • the dry powder may include one or more pharmaceutically acceptable excipient.
  • pharmaceutically acceptable excipients include, but are not limited to, lipids, metal ions, surfactants, amino acids, carbohydrates, buffers, salts, polymers, and the like, and combinations thereof.
  • lipids include, but are not limited to, phospholipids, glycolipids, ganglioside GM1 , sphingomyelin, phosphatide acid, cardiolipin; lipids bearing polymer chains such as polyethylene glycol, chitin, hyaluronic acid, or polyvinylpyrrolidone; lipids bearing sulfonated mono-, di-, and polysaccharides; fatty acids such as palmitic acid, stearic acid, and oleic acid; cholesterol, cholesterol esters, and cholesterol hemisuccinate.
  • the phospholipid comprises a saturated phospholipid, such as one or more phosphatidylcholines. Exemplary acyl chain lengths are 16:0 and 18:0 (i.e., palmitoyl and stearoyl). The phospholipid content may be determined by the active agent activity, the mode of delivery, and other factors.
  • Phospholipids from both natural and synthetic sources may be used in varying amounts. When phospholipids are present, the amount is typically sufficient to coat the active agent(s) with at least a single molecular layer of phospholipid. In general, the phospholipid content ranges from about 5 wt% to about 99.9 wt%, such as about 20 wt% to about 80 wt%.
  • compatible phospholipids comprise those that have a gel to liquid crystal phase transition greater than about 40 0 C, such as greater than about 60 0 C, or greater than about 80 0 C.
  • the incorporated phospholipids may be relatively long chain (e.g., C 16 -C22) saturated lipids.
  • Exemplary phospholipids useful in the disclosed stabilized preparations include, but are not limited to, phosphoglycerides such as dipalmitoylphosphatidylcholine, distearoylphosphatidylcholine, diarachidoylphosphatidylcholine, dibehenoylphosphatidylcholine, diphosphatidyl glycerols, short-chain phosphatidylcholines, hydrogenated phosphatidylcholine, E-100-3 (available from Lipoid KG 1 Ludwigshafen, Germany), long-chain saturated phosphatidylethanolamines, long-chain saturated phosphatidylserines, long-chain saturated phosphatidylglycerols, long-chain saturated phosphatidylinositols, phosphatidic acid, phosphatidylinositol, and sphingomyelin.
  • phosphoglycerides such as dipalmitoylphosphatidylcholine
  • metal ions include, but are not limited to, divalent cations, including calcium, magnesium, zinc, iron, and the like.
  • the pharmaceutical composition may also comprise a polyvalent cation, as disclosed in WO 01/85136 and WO 01/85137, which are incorporated herein by reference in their entireties.
  • the polyvalent cation may be present in an amount effective to increase the melting temperature (T m ) of the phospholipid such that the pharmaceutical composition exhibits a T m which is greater than its storage temperature (T 8 ) by at least about 20 0 C, such as at least about 40 0 C.
  • the molar ratio of polyvalent cation to phospholipid may be at least about 0.05:1 , such as about 0.05:1 to about 2.0:1 or about 0.25:1 to about 1.0:1.
  • An example of the molar ratio of polyvalent cation:phospholipid is about 0.50:1.
  • the polyvalent cation is calcium, it may be in the form of calcium chloride. Although metal ion, such as calcium, is often included with phospholipid, none is required.
  • the dry powder may include one or more surfactants.
  • one or more surfactants may be in the liquid phase with one or more being associated with solid particles or particulates of the composition.
  • compositions may incorporate, adsorb, absorb, be coated with, or be formed by the surfactant.
  • surfactants include, but are not limited to, fluorinated and nonfluorinated compounds, such as saturated and unsaturated lipids, nonionic detergents, nonionic block copolymers, ionic surfactants, and combinations thereof. It should be emphasized that, in addition to the aforementioned surfactants, suitable fluorinated surfactants are compatible with the teachings herein and may be used to provide the desired preparations.
  • nonionic detergents include, but are not limited to, sorbitan esters including sorbitan trioleate (SpanTM 85), sorbitan sesquioleate, sorbitan monooleate, sorbitan monolaurate, polyoxyethylene (20) sorbitan mon ⁇ laurate, and - polyoxyethylene (20) sorbitan monooleate, oleyl polyoxyethylene (2) ether, stearyl polyoxyethylene (2) ether, lauryl polyoxyethylene (4) ether, glycerol esters, and sucrose esters.
  • sorbitan esters including sorbitan trioleate (SpanTM 85), sorbitan sesquioleate, sorbitan monooleate, sorbitan monolaurate, polyoxyethylene (20) sorbitan mon ⁇ laurate, and - polyoxyethylene (20) sorbitan monooleate, oleyl polyoxyethylene (2) ether, stearyl polyoxyethylene (2) ether, lauryl polyoxyethylene (4) ether,
  • block copolymers include, but are not limited to, diblock and triblock copolymers of polyoxyethylene and polyoxypropylene, including poloxamer 188 (PluronicTM F-68), poloxamer 407 (PluronicTM F-127), and poloxamer 338.
  • ionic surfactants include, but are not limited to, sodium sulfosuccinate, and fatty acid soaps.
  • amino acids include, but are not limited to, hydrophobic amino acids. Use of amino acids as pharmaceutically acceptable excipients is known in the art as disclosed in WO 95/31479, WO 96/32096, and WO 96/32149, which are incorporated herein by reference.
  • carbohydrates include, but are not limited to, monosaccharides, disaccharides, and polysaccharides.
  • monosaccharides such as dextrose (anhydrous and monohydrate), galactose, mannitol, D-mannose, sorbitol, sorbose and the like; disaccharides such as lactose, maltose, sucrose, trehalose, and the like; trisaccharides such as raffinose and the like; and other carbohydrates such as starches (hydroxyethylstarch), cyclodextrins and maltodextrins.
  • buffers include, but are not limited to, tris or citrate.
  • acids include, but are not limited to, carboxylic acids.
  • salts include, but are not limited to, sodium chloride, salts of carboxylic acids, (e.g., sodium citrate, sodium ascorbate, magnesium gluconate, sodium gluconate, tromethamine hydrochloride, etc.), ammonium carbonate, ammonium acetate, ammonium chloride, and the like.
  • organic solids include, but are not limited to, camphor, and the like.
  • the dry powders of one or more embodiments of the present invention may also include a biocompatible polymer, such as biodegradable polymer, copolymer, or blend or other combination thereof.
  • a biocompatible polymer such as biodegradable polymer, copolymer, or blend or other combination thereof.
  • useful polymers comprise polylactides, polylactide-glycolides, cyclodextrins, polyacrylates, methylcellulose, carboxymethylcellulose, polyvinyl alcohols, polyanhydrides, polylactams, polyvinyl pyrrolidones, polysaccharides (dextrans, starches, chitin, chitosan, etc.), hyaluronic acid, proteins, (albumin, collagen, gelatin, etc.).
  • the delivery efficiency of the composition and/or the stability of the dispersions may be tailored to optimize the effectiveness of the active agent(s).
  • compositions e.g., latex particles
  • the rigidifying components can be removed using a post-production technique such as selective solvent extraction.
  • the dry powder may also include mixtures of pharmaceutically acceptable excipients.
  • mixtures of carbohydrates and amino acids are within the scope of the present invention.
  • the powders are filled into the receptacle, they are conditioned as described in PCT/US2008/012117, filed October 23, 2008, which is incorporated herein by reference.
  • the present is generally used with dry powders having an MMD and/or MMAD of less than 30 ⁇ m, such as less than 20 ⁇ m or less than 10 ⁇ m, and MMD and/or MMAD typically range from 1 ⁇ m to 10 ⁇ m, such as 1 ⁇ m to 5 ⁇ m.
  • the apparatus disclosed herein is significantly smaller than known devices while also having comparable performance.
  • the apparatus can be designed to have a one-month useful life and does not require any deoccluding or replacement of parts by the user.
  • the device can therefore be made disposable.
  • the apparatus is also preferably easier to use, is ergonomic, and has a look-and-feel which is more desirable than known devices.
  • the apparatus can be made small and lightweight for easy storage and can desirably easily fit within a user's shirt or pants pocket.
  • the apparatus also desirably fits in the palm of the user and requires few puffs for a dose, e.g., 1 to 4 puffs, such as 1 to 3 puffs or 1 to 2 puffs.
  • FIGS. 1 and 2 there is shown a non- limiting embodiment of the apparatus according to the invention.
  • the apparatus may have a height "h" which is typically 50 mm to 80 mm, such as approximately 60 mm and a width "w" which is typically 30 mm to 60 mm, such as approximately 40 mm, and a depth is typically 20 mm to 50 mm, such as approximately 30 mm.
  • h typically 50 mm to 80 mm
  • w width
  • a depth is typically 20 mm to 50 mm, such as approximately 30 mm.
  • FIG. 1 shows the apparatus with a cap or protective cover A installed thereon
  • FIG. 2 shows the apparatus with the cap A removed. As is shown in FIG.
  • FIGS. 3-8 show one non-limiting way in which the apparatus of the type described herein and, in particular, of the type shown in FIGS. 1-2 can be used by a user.
  • FIG. 3 shows the apparatus prior to the cap A being removed.
  • the cap A can be removed by merely lifting the cap A vertically.
  • the cap A is also configured and therefore capable of being mated with or mounted to the bottom portion of the apparatus to prevent its loss and to increase the surface area available to the user for gripping the apparatus during use. With the cap removed, FIG.
  • FIG. 4 shows how a receptacle Q can be inserted into the opening in the apparatus.
  • the receptacle Q can be slid into the opening of the apparatus horizontally.
  • FIG. 5 shows how an upper housing portion (i.e., the housing portion containing the mouthpiece B) of the apparatus can be rotated to activate the apparatus.
  • the apparatus automatically performs the following functions: the lock system M is moved to the unlocked position and the receptacle impacting member N is activated so as to impact a tub portion of the receptacle Q.
  • the upper housing portion or mouthpiece B can be rotated clockwise.
  • the angle of rotation in this embodiment is about 180 degrees.
  • rotation would not be possible unless the receptacle Q has been properly inserted.
  • rotation is made possible because the lock system N has moved to the unlocked position by proper insertion of the receptacle Q.
  • the apparatus automatically performs the following functions: the air inlet openings and the central outlet opening are formed (e.g., as is shown in FIG. 102) in the foil lidstock of the receptacle Q and the inside of the feed tube FT is deoccludeed by the deoccluding device G.
  • FIG. 6 shows how the air flow can come out through the mouthpiece B. Of course, this will occur when the user places his or her lips on the mouthpiece B and inhales by an amount that is sufficient to open the trigger E.
  • FIG. 7 shows how a spent or used receptacle Q can be removed from the opening in the apparatus. As the arrow demonstrates, the receptacle Q can be slid out of the opening of the apparatus horizontally.
  • FIGS. 9-24 show one non-limiting way in which the apparatus shown in FIGS. 1-2 can be assembled.
  • FIG. 9 shows an exploded view of the apparatus: component A represents the cap; component B represents the mouthpiece; component C represents a coil compression spring; component D represents a retainer or retainer member; component E represents the trigger; component F represents the orifice member; component G represents the deoccluding and puncturing device; component H represents the receptacle puncturing mechanism; component I represents the upper bearing member; component J represents the lower bearing member; component K represents the support body member; component L represents the skirt; component M represents the lock member; component N represents the receptacle impacting member; component O represents a torsion spring; and component P represents the lower housing part.
  • component Q represents a receptacle which can be used with the apparatus.
  • the part count of the above embodiment is 16 parts. By combining and/or eliminating parts, the part count may be 16 or less, such as 15 or less, 14 or less, 13 or less, or 12.
  • component F may be omitted.
  • Component J and the outer portions of components K and P may be combined.
  • Components O and M and the inner portion of component K may be combined.
  • component E may be omitted.
  • At least components A, B, D 1 F, H- N, and P can made by injection molding and can be made of materials conventionally used in, e.g., commercially available insulin inhalation devices.
  • Non-limiting materials include a wide range of plastics, such as PBT, ABS, polycarbonates, and liquid crystal polymers.
  • Commercially available plastics include Ticona Celanex MT2401 or MT2402 (PBT), GE Cycoloy C1950 or C1204HF (PC/ABS), Basell ProFax PF-511 (PP).
  • the cap or component A can be made of PP supplied by Basell or PC/ABS supplied by GE, and the material can have a grade of ProFax PF-511 or a grade of Cycoloy C1950 or C1204HF.
  • the mouthpiece or component B can be made of PC/ABS supplied by GE, and the material can have a grade of Cycoloy C1950 or C1204HF.
  • the trigger retainer or component D can be made of PP supplied by Basell, Ticona Celanex MT2401 or MT2402 (PBT), or PC/ABS supplied by GE, and the material can have a grade of ProFax PF-511 or a grade of Cycoloy C1950 or C1204HF.
  • the trigger E can be made of an elastomer, e.g., silicone or thermoplastic elastomers.
  • the orifice member or component F can, e.g., be made of PP supplied by Basell or PC/ABS supplied by GE, and the material can have a grade of ProFax PF-511 or a grade of Cycoloy C1950 or C1204HF.
  • the orifice member F may be made of rubber to allow flexing and self-deoccluding.
  • the cutter mechanism or component H can, e.g., be made of PBT supplied by Ticona and the material can have a grade of Celanex MT2401 or MT2402.
  • the upper bearing member or component I can, e.g., be made of PC/ABS supplied by GE, and the material can have a grade of Cycoloy C1950 or C1204HF.
  • the lower bearing member or component J can, e.g., be made of PC/ABS supplied by GE or PBT supplied by Ticona and the material can have a grade of Cycoloy C 1950 or C1204HF or a grade of Celanex MT2401 or MT2402.
  • the body member or component K can, e.g., be made of PC/ABS supplied by GE, and the material can have a grade of Cycoloy C1950 or C1204HF.
  • the skirt or component L can, e.g., be made of PC/ABS supplied by GE, and the material can have a grade of Cycoloy C1950 or C1204HF.
  • the lock member or component M can, e.g., be made of PC/ABS supplied by GE, and the material can have a grade of Cycoloy C1950 or C1204HF.
  • the receptacle impact member or component N can, e.g., be made of PC/ABS supplied by GE 1 and the material can have a grade of Cycoloy C1950 or C1204HF.
  • the lower housing or component P can, e.g., be made of PC/ABS supplied by GE, and the material can have a grade of Cycoloy C1950 or C1204HF.
  • FIG. 10 shows how the deoccluding and puncturing device G can, e.g., be seated inside the receptacle puncturing mechanism H.
  • an orifice member F can, e.g., be mounted to the cutter mechanism H.
  • the orifice member F is optional and can, e.g., be omitted from the apparatus.
  • the trigger E can then be mounted to the orifice member F.
  • the retainer member D is mounted over the trigger E.
  • FIG. 14 shows how the upper bearing member I is mounted to the lower bearing member J.
  • FIG. 14 shows how the upper bearing member I is mounted to the lower bearing member J.
  • FIG. 16 shows the spring C thereafter being mounted within the upper bearing member I.
  • the mouthpiece B can then be mounted to the sub-assembly of components C-J as shown in FIG. 17.
  • FIG. 18 shows how the torsion spring O can, e.g., be mounted to the lower housing member P.
  • FIG. 19 shows how the receptacle impacting member N can, e.g., be mounted to the lower housing member P and the torsion spring O.
  • FIG. 20 shows how the lock member M can then be mounted to the lower housing member P.
  • FIG. 21 shows how the skirt L is mounted to the lower housJngjTiember P.
  • FIG. 22 shows how the housing member K is mounted to the skirt L and the lower housing member P.
  • FIG. 23 shows how the sub-assembly of components B-J are mounted to the sub-assembly of components K-P.
  • FIG. 24 shows the fully assembled apparatus after assembly and with the cap A installed thereon.
  • FIGS. 25-27 show various cross-sectional views of one non-limiting embodiment of the apparatus shown in FIGS. 1-2.
  • FIG. 25 shows a cross- section view of FIG. 1.
  • FIG. 26 shows a cross-section view of FIG. 2 turned 90° relative to FIG. 25.
  • FIG. 27 shows a cut-away perspective view of the apparatus shown in FIGS. 1-2.
  • the trigger E is shown in both the closed position and the open position (for purposes of illustration) and a receptacle Q is positioned in the home position or fully inserted position.
  • the trigger E would not normally be opened, and the receptacle would not normally be inserted, while the cap is still installed thereon.
  • FIGS. 28-31 show various views of one non-limiting embodiment of the cap A shown in FIG. 9 and illustrate the various features thereof.
  • the cap A covers and protects mouthpiece B and the receptacle insertion slot S from ingress of dirt and debris between uses.
  • the cap A in this embodiment has a generally oval configuration and includes a front section 10g and a rear section 10h.
  • the cap A also has a closed upper end 10a and an open lower end 10d which is sized and shaped to slide over the mouthpiece B.
  • the cap A utilizes two oppositely arranged projections 10e which are configured to engage with indentations formed in member J.
  • the cap A also utilizes internal elongated projections 10f which are configured to frictionally engage with outer surfaces of the mouthpiece B so as to prevent the cap A from moving excessively laterally when installed on the apparatus.
  • the cap A can be inverted onto the bottom of the device during dosing to provide additional grip surface.
  • the cap A can, e.g., be made of the materials described above and can even be made transparent or translucent.
  • the cap A can also be dispensed with (or replaced with a removable plug-type cap which fits within the exit opening of the mouthpiece B) as it is not required for a proper functioning apparatus.
  • FIGS. 32-39 show various views of one non-limiting embodiment of the upper housing portion or mouthpiece B shown in FIG. 9 and illustrate the various features thereof.
  • the mouthpiece B generally provides a smooth, elliptical surface to seal against the user's lips during inhalation.
  • the mouthpiece B in this embodiment has a generally oval configuration and includes a front section 20a and a rear section 20b.
  • the mouthpiece B also has a closed upper end 20c which is sized and configured to allow a user's lips to sealingly engage with the mouthpiece B and thereby allow the user to breathe in without any significant leakage between the user's lips and the upper end 20c.
  • the mouthpiece B is shaped to keep the user's tongue from getting in the way, which increases the emitted dose and reproducibility of results.
  • the mouthpiece B has a length sufficient to protrude past the teeth of the user.
  • the mouthpiece B also has an open lower end 2On which is sized and shaped to slide over the upper bearing member I.
  • the mouthpiece B utilizes two oppositely arranged projections 2Oh whose free ends are configured to enter openings 9Od and to become fixed to portions 90c formed on upper bearing member I by, e.g., ultrasonic welding, swaging, etc.
  • the projections 2Oh thus, function as internal ribs on the major axis of the mouthpiece B and may facilitate ultrasonic welding of upper subassembly B- J.
  • the projections 2Oh can each have a generally T-shaped cross-section.
  • the mouthpiece B also utilizes finger engaging indentations or grips 2Od and 2Oe which are ergonomically shaped to allow the user to grip the mouthpiece B with the thumb and forefinger when the user rotates the mouthpiece B.
  • the mouthpiece B additionally also utilizes a generally oval-shaped diverging exit opening 2Og which extends from upper edge 20l/20k to a generally circular opening 2Of.
  • the generally oval-shaped diverging exit opening 2Og allows the aerosolized powder to expand as it moves from the opening 2Of to exit opening edge 20l/20k.
  • the front and back exit opening edges 201 each have a generally outward curving shape whereas the left and right exit opening edges 20k each gave a generally inwardly curving shape.
  • a plurality of reinforcing ribs 2Oi is arranged on the wall 2Oj, which forms the generally oval : shaped diverging exit opening 2Og.
  • the plurality, e.g., eight, of reinforcing ribs 2Oi provides support for compression spring C.
  • the generally circular opening 2Of is defined by a generally circular wall which includes an outer circumferential surface 20o.
  • the outer circumferential surface 2Oo is sized and shaped to slide within (see FIGS. 25-27) and/or sealingly engage with inner circumferential surface 4Od of member D.
  • a pair of inwardly projecting spaced-apart ribs 2Op is arranged on each of the walls which form the front and back sections 20a and 20b. Each oppositely arranged pair of ribs 2Op are sized and configured to slide within the oppositely arranged slots 9Of and 9Og of the upper bearing member I. Each oppositely arranged pair of ribs 2Op is also arranged on one of two oppositely arranged curved indentations 2Oq. These indentations 2Oq are sized and configured to receive therein outwardly curved projecting portions 90m of the upper bearing member I.
  • the mouthpiece B also utilizes oppositely arranged indentations 2Or 1 which are sized and configured to receive therein outwardly curved free ends of the projecting portions 90b and 90c of the upper bearing member I.
  • the projections 2Oh, the indentations 2Oq and 2Or, and the projections 2Op all function to couple the upper bearing member I to the mouthpiece B and ensure that the mouthpiece B causes rotation of the upper bearing member I when the mouthpiece B is rotated.
  • the mouthpiece B can, e.g., be made of the materials described above and can even be made transparent or translucent.
  • FIGS. 40-43 show various views of one non-limiting embodiment of the retainer member D shown in FIG. 9 and illustrate the various features thereof.
  • the retainer member D fits against the orifice member F.
  • An upper portion of the retainer member D is slidingly sealed against mouthpiece B.
  • the retainer D has a generally circular sleeve configuration and includes an open upper end 40a and an open lower end 40b.
  • the retainer D has a generally cylindrical outer surface 40c and an inner generally cylindrical surface 40d which is sized and configured to sealingly engage with the cylindrical surface 2Oo of the mouthpiece B.
  • the retainer D also has an upper shoulder surface 40h and a lower shoulder surface 40g formed in an inwardly projecting circumferential projection 4Oi.
  • the lower shoulder surface 4Og and the inner circumferential surface 40f are sized and configured to correspondingly sealingly engage with surfaces 5Oh and 5Oe of the trigger E.
  • An inwardly projecting circumferential projection 40j is sized and configured to correspondingly sealingly and lockingly (and/or non-removably) engage with circumferential projection 60c of the orifice member F.
  • the retainer D utilizes a chamfered portion 40e.
  • the retainer D can, e.g., be made of the materials described above and can even be made transparent or translucent.
  • FIGS. 44-47 show various views of one non-limiting embodiment of the trigger member E shown in FIG. 9 and illustrate the various features thereof.
  • the Trigger E minimizes flow through the device and receptacle Q until a minimum threshold vacuum is achieved.
  • the trigger E opens suddenly providing a rapid pulse of air through the receptacle Q and device to aid in receptacle Q evacuation and powder deagglomeration.
  • a star-shaped opening of the trigger E during inhalation serves to deagglomerate the powder.
  • the motion of the trigger E prevents excessive build-up of powder on the trigger surfaces.
  • the opening of the trigger E gives the patient feedback of proper operation of the device.
  • a wedge-shaped flange of the trigger E keeps the part from being pulled out of its mounting during inhalation.
  • the trigger E has a generally circular configuration and includes an open upper end which includes a circumferential projecting shoulder 5Oj and a normally closed lower end 50a.
  • the trigger E has a generally cylindrical outer surface 5Oe and a tapered surface 5Oh which is sized and configured to sealingly engage with surfaces 40g and 40f of the retainer D.
  • the trigger E additionally has an upper tapered surface 5Oi which is sized and configured to sealingly engage with tapered surface 60b of the orifice member F.
  • a flexible material wall section 5Og connects the section 50a/50b to the section with the tapered surfaces 5Oi and 5Oh of the trigger E. As was shown in FIGS.
  • the wall 5Og is configured to allow the trigger E to assume an open position during use of the apparatus and of assuming a closed position when not in use.
  • Two slits 50c and 5Od are arranged on the sections 50a and 50b. These slits 50c and 5Od form the opening of the trigger E when the wall 5Og inverts from the normally closed position to the open position.
  • the trigger E can be made of the materials described above and can even be made transparent or translucent.
  • FIGS. 48-50 show various views of one non-limiting embodiment of the orifice member F shown in FIG. 9 and illustrate the various features thereof. As is shown in FIGS.
  • the orifice member F has a generally circular configuration and includes an open upper end 60a and an open lower end.
  • the orifice member F also has a generally circular opening 6Oj which is sized to allow a predetermined aerosolized flow through the apparatus.
  • the orifice member F also has a shoulder 6Od which is configured to abut end 40b of the retainer D when the retainer D and the orifice member F are non- removably connected to each other.
  • a generally planar surface 60k and a generally curved surface 6Oi are sized and configured to generally correspond to and abut generally planer surface 50a and curved surface 50b of the trigger E when the retainer D and the orifice member F are non-removably connected to each other with the trigger E arranged therebetween.
  • the orifice member F also has an annular projecting shoulder 6Of whose outer circumferential surface 6Og is sized and configured to frictionally and sealingly engage with inner circumferential surface of shoulder 8Og of the cutter mechanism H.
  • the outer circumferential surface 6Og is adhesively and/or non- removably secured to inner circumferential surface of shoulder 8Og of the cutter mechanism H so that the subassembly of parts D, E and F are secured to the cutter mechanism H allowing these parts to move together during activation of the apparatus.
  • the deoccluding device G is axially secured between the orifice member F and the cutter mechanism H and is therefore capable of both rotating with the cutter mechanism H and moving axially with the cutter mechanism H.
  • FIGS. 51-52 show various views of one non-limiting embodiment of the deoccluding member G shown in FIG. 9, and illustrate the various features thereof.
  • the deoccluding member G is an integral part of the aerosol module D-H, telescoping and rotating to create the central hole in the receptacle Q. Upon each actuation of the device, the deoccluding member G is rotated 180° relative to the feed tube FT to prevent clogging of the drug path. The wings of the deoccluding member G engage features in the cutter mechanism H and prevent the deoccluding member G from coming completely free. [0305] As is shown in FIGS. 51-52, the deoccluding member G has the form of a bent wire configuration and includes upper free ends 70a and 70b and a lower rounded puncturing end 7Og.
  • the upper free ends 70a and 70b and the connecting portions 70c and 7Od are sized and configured to seat within the oppositely arranged pairs of projections 8Of of the cutter mechanism H (see FIG. 10).
  • the lower rounded puncturing end 7Og is sized and configured to puncture and tear open the exit opening of the receptacle Q (see FIG. 102).
  • the deoccluding member G also has two generally vertical deoccluding portions 7Oe and 7Of which are sized and configured to either ride just above or scrape against the inner surface of the feed tube FT (see FIG. 68).
  • the two generally vertical deoccluding portions 7Oe and 7Of can preferably be angled to correspond to the tapered surface of the feed tube FT.
  • the deoccluding member G can also be integrally formed with one of the other components of the apparatus such as, e.g., the cutter mechanism H or the orifice member F.
  • the deoccluding member G can be made of the materials described above and can even be made transparent or translucent.
  • FIGS. 53-59 show various views of one non-limiting embodiment of the cutter mechanism member H shown in FIG. 9, and illustrate the various features thereof.
  • Teeth 8Ot of the cutter mechanism H create inlet holes in the lidstock of the receptacle Q. Holes 8Oe allow bypass air to enter the aerosol module D-H to keep the overall resistance of the device at a desired level.
  • Four radial ribs 8Of locate and constrain the deoccluding device G.
  • the orifice member F and the cutter mechanism H together form a flange to transmit the force of the compression spring C to the aerosol module D-H.
  • Wedge-shaped recesses on the outer cams 80o, 8Op provide a detent for the home position of the mouthpiece B rotation and discourage reverse rotation from the home position.
  • Central bore 80k of the cutter mechanism H creates a telescoping and rotating seal to the feed tube FT.
  • the cutter mechanism H has a generally circular configuration and includes an open upper end 80a having two oppositely arranged projections 80b and 80c. Projection 80b is sized and configured to fit within and slide up in either slot 9Oh or slot 9Of of the upper bearing member I.
  • Projection 80c is sized and configured to fit within and slide up in the other of either slot 9Oh or slot 9Of of the upper bearing member I.
  • the cutter mechanism H also has a generally circular opening 80k which is sized and configured to receive therein in a sealingly manner the upper end of the feet tube FT.
  • the engagement between the generally circular opening 80k and the upper end of the feed tube FT utilizes a very small to essentially zero clearance, acts to center the cutter mechanism H in the apparatus and thereby determine the proper position of the teeth 8Ot to precisely form the two arc-shaped inlet openings in the receptacle Q, and also serves as the mounting (or bushing and/or bearing) that allows the cutter mechanism H to rotate and move axially relative to the feed tube FT.
  • the rotational movement is, of course, caused by rotation of the mouthpiece B while the axial movement of the cutter mechanism H is determined by the relative position of the surfaces 801 of relative to surface 100a of member J.
  • Rotational contact between the surfaces 8Ol and surface 100a occurs during the tearing of the inlet openings in receptacle Q and contact between the surfaces 8Ol and surfaces of members 10Ob 1 i.e., the generally horizontal surfaces between surfaces 100c and 100d and between 100e and 100 ⁇ , occurs when the mouthpiece B is in one of the two 180 degree activation-ready positions.
  • contact between the surfaces 8Ol and surface 100a means that the teeth 8Ot are in the fully extended position (i.e., penetrating into the lidstock of receptacle Q) and contact between the surfaces 8Ol and the generally horizontal surfaces of members 100b means the teeth 8Ot are in a retracted position.
  • the spring C biases the cutter mechanism H towards the member J and thus functions to cause the axial movement of the cutter mechanism H towards the member J.
  • the cutter mechanism H also has oppositely arranged notches each defined by a generally vertical surface 8Oo and an angled surface 8Op whose design is such as to only permit rotation of the cutter mechanism H in the clockwise direction.
  • the cutter mechanism H also utilizes two oppositely arranged pairs of projections 8Of which receive the free ends of the deoccluding device G as described above.
  • the cutter mechanism H further also utilizes two oppositely arranged angled cam surfaces 80m which are configured to engage surfaces 100c and 100d of the member J and, when so engaged, causes axial movement of the cutter mechanism H away from the receptacle Q.
  • Two other oppositely arranged angled cam surfaces 8On are configured to engage surfaces 100f of the member J and, when so engaged, allow axial movement of the cutter mechanism H towards the receptacle Q under the biasing force of the spring C.
  • Angled surfaces 8Ou allow the cutter mechanism H to avoid contacting portions 100t of the member J when the cutter mechanism H is rotating.
  • Surfaces 8Or are configured to contact portions 100t of the member J when the cutter mechanism H is in the two 180 degree pre-activated positions.
  • a plurality of equally sized, e.g., six, through openings 8Oe are arranged on angled wall 8Od and allow bypass airflow to pass through the cutter mechanism H and then through the orifice opening 6Oj.
  • Each of the two teeth 8Ot is arranged on a tooth support 80s sized and configured to prevent deflection of the teeth 8Ot during cutting or tearing.
  • other configurations and shapes for the cutter mechanism H are contemplated.
  • the cutter mechanism H can be made of the materials described above and can even be made transparent or translucent.
  • Considerations in the design of the feet tube FT should include a concern for maintaining an accelerating air flow up through the feed tube FT; and ensuring that the opening shape or configuration minimized or avoids boundary layer separation.
  • the cutter mechanism H can be designed so that the center outlet opening in the lidstock is formed either prior to the two arc-shaped inlet openings or simultaneously therewith (see e.g., FIG. 102).
  • the end 7Og can be arranged to have the same axial distance as the end of the teeth 8Ot.
  • the end 7Og can instead be arranged to have a smaller axial distance than the end of the teeth 8Ot so that the teeth 8Ot puncture the lidstock before the end 7Og when the cutter mechanism H is moved towards the lidstock of the receptacle Q.
  • the lower end (or inlet end) of the feed tube FT is also preferably in contact with the lidstock during puncturing of the openings and/or when the user activates the trigger E by inhalation.
  • This contact provides a temporary seal and ensures that nearly all of the air/powder flow out of the receptacle Q is directed up through the feed tube FT.
  • a perfect seal in this area is not necessary, however.
  • Acceptable sealing contact can include, among other things, contact which is sufficient to place the lidstock of the receptacle Q in tension.
  • FIGS. 60-65 show various views of one non-limiting embodiment of the upper bearing member I shown in FIG. 9, and illustrate the various features thereof.
  • the upper bearing member I provides surfaces for ultrasonically welding to the mouthpiece B.
  • the upper bearing member I has a generally square configuration and includes open upper and lower ends and two oppositely arranged projecting portions 90b and 90c. Projections 90b and 90c are sized and configured to fit within recesses 2Or of mouthpiece B. Projections 90b and 90c each utilize two support flanges 9Oe arranged on oppositely arranged walls 90a and an opening 9Od sized to receive therein the projections 2Oh of mouthpiece B.
  • the upper bearing member I also has two oppositely arranged projecting wall portions 90m.
  • One of these projecting wall portions 90m includes slot 9Of and the other of the projecting wall portions 90m includes upper slot 9Og and lower slot 9Oh.
  • the upper portion of slot 9Of is sized and configured to receive therein the pair of ribs 2Op of the mouthpiece B while the upper slot 9Og is sized and configured to receive therein the oppositely arranged pair of ribs 2Op of the mouthpiece B.
  • the lower portion of slot 9Of is sized and configured to slidingly receive therein the projection 80c of the cutter mechanism H while the lower slot 9Oh is sized and configured to slidingly receive therein the oppositely arranged projection 80b of the cutter mechanism H.
  • the upper bearing member I also has a generally circular opening 901 which is sized and configured to rotatably engage circumferential surface 100a1 of the member J.
  • the bottom surface 90k of upper bearing member I is configured to frictionally engage with upper surface 100j of member J while the upper surface 9Oj of upper bearing member I frictionally engages with lower surface 100a2 of member J.
  • Such contact functions to create two bearings and ensures that the upper bearing member I can rotate relative to the member J while also ensuring that the upper bearing member I does not move substantially axially relative to the member J.
  • the upper bearing member I becomes fixed to the mouthpiece B and because the member J becomes fixed to the lower housing P 1 these engaging surfaces provide the rotatable and not separable connection between the upper portion of the apparatus formed by parts B-I and the lower portion of the apparatus formed by parts J-P.
  • the upper bearing member I also functions as part of the receptacle lock system described above.
  • the upper bearing member I includes four recesses 9On which are sized and configured to receive therein ends 130a of the locking member M when the ends 130a are moved to the locking position. When the locking member M is not in the locking position, the free ends 130a do not extend into recesses 9On and instead remain underneath surface 90o.
  • the upper bearing member I can be made of the materials described above and can even be made transparent or translucent.
  • FIGS. 66-72 show various views of one non-limiting embodiment of the lower bearing member J shown in FIG. 9, and illustrate the various features thereof.
  • a circular flange 100a1 at the top of the lower bearing member J constrains the flange 9Ol of the upper bearing member I to hold the upper half and lower half of the device together.
  • the feed tube FT provides a conduit for aerosol to exit receptacle Q and enter the aerosol module D-H.
  • the feed tube FT provides a rotating and telescoping seal to the aerosol module D-H.
  • Cams 100c, 100d, 100f on the circular flange 100a1 of the lower bearing member J engage cams 80m, 8On on the underside of the cutter mechanism H to raise and lower the aerosol module D-H.
  • Wedge- shaped teeth 100d on the outer cams provide a detent for the home position of the mouthpiece B rotation and discourage reverse rotation from the home position.
  • Arc-shaped holes 100m on the top of the lower bearing member J provide clearance for the projections 130a of lock member M.
  • the member J has a generally oval configuration and includes an upper end 100a having two oppositely arranged projections 100b. Projections 100b function to control the axial position of the cutter mechanism H as the cutter mechanism H rotates to ensure that the cutter mechanism H can only rotate clockwise (as was described above).
  • the surface 100a2 forms an upper bearing with surface 9Oj and the surface 100g forms a lower bearing with surface 90k.
  • the surface 100a1 forms a bearing with surface 90I.
  • the former upper and lower bearings ensure that upper bearing member I is axially retained while the latter bearing ensures that the upper bearing member I remains coaxial with the feed tube FT.
  • the member J also utilizes oppositely arranged lower flange portions 10Oo which are sized and configured to seat within oppositely arranged support shoulders 110k of member K.
  • the lower flange portions 10Oo each include a through opening 10Oi sized and configured to receive therein one of the free ends of projections 160c of member P.
  • the member J also utilizes a front facing main projection 10Oj which includes sides 100k and 1001 that are sized and configured to seat within a main front recess of member K defined by surfaces 110m, 1101 and 110n of member K.
  • a feed tube FT is arranged on the member J and functions to direct and/or convey the aerosolized airflow from the outlet opening formed in the receptacle Q up through the apparatus before passing through the central opening of the orifice member F.
  • the feed tube FT includes lower tapered surface 100s which is configured to sealingly engage and/or contact the lidstock of the receptacle Q when the receptacle Q is installed in the apparatus.
  • the feed tube FT utilizes a through opening having a larger upper end 100q and a smaller lower end 100r and is generally tapered and is connected to the member J via two oppositely arranged spoke- like members each having an enlarged portion 100t and a smaller portion 100u.
  • the two open areas defined by the inner cylindrical surface of the wall 100a1 and the two oppositely arranged spoke-like members each having an enlarged portion 100t and a smaller portion 100u allow for bypass air to flow up through the member J and also serves a storage area for inlet air which will flow into the inlet openings formed in the lidstock of the receptacle Q.
  • the member J also has a centrally disposed tapered inlet guide surface 100x which extends across the main projection 100j.
  • FIGS. 73-78 show various views of one non-limiting embodiment of the support body member K shown in FIG. 9, and illustrate the various features thereof.
  • a central rectangular opening 110j provides clearance for the receptacle impacting member N.
  • the member K has a generally oval configuration and includes an upper support surface 110d having a main generally rectangular opening 110j and two outer openings 110e.
  • the opening 110j functions to, among other things, allow ends 140a-140c of the receptacle impacting member N to pass therethrough and allow the member N to rotate upon insertion of the receptacle Q.
  • the openings 110e function to, among other things, allow the ends 130a of the lock member M to pass therethrough and to move upon insertion of the receptacle Q.
  • Two ramp- shaped support projections 110k are arranged on the surface 110d and function to lift slightly the receptacle Q during its insertion.
  • a main generally spherical recess 110h is located in a central area of the member K and functions to correctly position and support the tub portion of the receptacle Q.
  • a generally curved recess 110i extends from the recess 110h to an entrance area of the member K and functions to allow the tub portion of the receptacle Q to pass into the apparatus.
  • the entrance area is defined by a recess which includes oppositely arranged side edges 1101 and 110n and bottom edge 110m. The two oppositely arranged side edges 1101 and 110n are spaced to receive therein the projecting portion 100j of member J and are configured to abut edges 100k and 1001.
  • Two arc-shaped support surfaces 110f are arranged above the spherical recess 110h and function to support the bottom side surface of the receptacle Q while the recess 110h supports the tub portion of the receptacle Q. Additionally, two oppositely arc-shaped support shoulders 110k are arranged to support the oppositely arranged projecting portions 100o of member J. The front and back arc-shaped support shoulders 110c are arranged to support the peripheral portion of the outer surface 10Op of member J.
  • the member K also utilizes slots 110s which are sized and configured to receive upper portions of projections 12Oh of member L.
  • the member K additionally also utilizes two oppositely arranged indentations 110t which function to allow air to enter into the apparatus.
  • Member K When the members K and L are assembled together, a small space remains between bottom edge 110u and shoulder 12Og and a larger space between indentations 110t and the indentations 12Oi.
  • Member K also utilizes two bottom facing projections 110q and 110o which have circular recesses 110r and 110p that form bearings for the two ends 13Oh of lock member M.
  • the ⁇ member K can be made of the materials described above and can even be made transparent or translucent.
  • FIGS. 79-83 show various views of one non-limiting embodiment of the skirt member L shown in FIG. 9, and illustrate the various features thereof.
  • the skirt member L provides tamper resistance by covering the holes in the body J required to snap the lower half subassembly together.
  • the skirt member L may provide trade dress.
  • the skirt member L may provide a location for the patient to write on the device, e.g., the date of first use.
  • the member L has a generally oval configuration and includes an upper edge 120a having a generally inwardly curved front and rear edges and generally outwardly curved left and right sides edges.
  • the member L also includes a lower edge 120b having a generally inwardly curved front and rear edges and generally outwardly curved left and right sides edges.
  • Two oppositely arranged indentations 12Oi are on inner portions of the left and right sides of the member L and function to allow air to enter into the apparatus.
  • the member L also utilizes projections 12Oh whose upper ends are sized and configured to engage slots 110s of the member K and whose lower ends are sized and configured to engage slots 16Od of the member P.
  • the member L additionally also utilizes an inwardly facing peripheral shoulder 12Og. When the members L and P are assembled together, there remains a small space between the upper edge 160b and shoulder 12Og and a larger space between indentations 12Oj and the indentations 16Og.
  • Member L also utilizes two front and back oppositely arranged indentations 12Oe and 12Of.
  • the member L can be made of the materials described above and can even be made transparent or translucent.
  • FIGS. 84-87 show various views of one non-limiting embodiment of the lock member M shown in FIG. 9, and illustrate the various features thereof.
  • Ends 130a are biased inwards to follow the profile of the receptacle Q during insertion. If the receptacle Q is not fully inserted, the ends 130a engage details on the underside of the upper bearing member I that prevent rotation of the mouthpiece B. The ends 130a are biased inwards and engage side notches 17Og in the receptacle Q outline to pull the receptacle Q into the device. Once the mouthpiece B is rotated, ends 130a prevent receptacle Q insertion or removal until the mouthpiece B is returned to the home position.
  • the lock member M has a main connecting portion 13Oe having a reinforcing shoulder 13Of and connecting together, via two flexible connecting web portions 13Od, two plate-like members 130b.
  • Each web portion 13Od functions as a spring so that when the plate members 130b are rotated about the axes of the members 130c (as will typically occur upon insertion of the receptacle Q into the apparatus), the web portions 13Od are stressed and function to bias the members 130b towards the original non-stressed state shown in FIGS.
  • the lock member M also includes upper bearing shaft portions 13Oh which are sized and spaced to engage recesses 110r and 110p of member K and lower bearing shaft portions 13Og which are sized and spaced to engage recesses 1601 and 16Oj of member P.
  • a bottom surface 13Oj of the member M and two optional bottom projections 13Oi function to vertically support the member M within the member P.
  • the member M also utilizes projections 130a whose upper ends are spaced apart to receive the leading end of the receptacle Q and which can be moved apart thereby during insertion of the receptacle Q. These ends 130a are also configured to seat within oppositely arranged recesses 17Og of the receptacle Q.
  • the lock member M can also utilize a single end portion 130a and/or a single plate-like member 130b since only one of these is required to cause a locking of the apparatus.
  • a single end portion 130a and/or a single plate-like member 130b since only one of these is required to cause a locking of the apparatus.
  • the member M can be made of the materials described above and can even be made transparent or translucent.
  • FIGS. 88-92 show various views of one non-limiting embodiment of the receptacle impacting member N shown in FIG. 9, and illustrate the various features thereof.
  • the receptacle impacting member N Upon insertion of the receptacle Q into the device, the receptacle impacting member N provides an impact to the receptacle tub 17Oh to help break up powder.
  • the insertion of the receptacle Q drives the mechanism due to the recesses 14Oe on the end of each arm 14Oa 1 140b, 140c of the receptacle impacting member N.
  • the member N has a generally triangular configuration and includes a main portion having three generally identical arms 140a-140c extending therefrom.
  • the axial end surfaces of the portions 140h and 140g are sized and configured to movably engage with inner facing surfaces of plate-like projections 16Oe of member P.
  • the plate- like projections 16Oe of member P also function to limit axial movement of the member N and ensure that the arms 140a-140c move freely within the recess 110j.
  • the member N is designed to rotate and move up and down when mounted to the member P.
  • the member N includes two oppositely arranged axial projections 14Oi and 140j which are sized and configured to rotate and move vertically between the slots formed between the projections 16Of and 16Oe.
  • Each arm 140a-140c includes an upper lip portion 140d and a recess 140e which is designed to receive the leading end of the receptacle Q.
  • the leading end of the receptacle Q with slide beneath the upper lip 140d and engage the shoulder 14Of of recess 14Oe, and further insertion movement of the receptacle Q will cause the member N to rotate about the axis of the projections 14Oi and 140j.
  • Such rotation also causes the member N to move downwards between the slots formed between the projections 16Of and 16Oe. This downward movement is resisted by the free ends 150a and 150b of the torsion spring O which causes the member N to back upwards as the receptacle Q is moved to a final insertion position in the apparatus.
  • the member N can be made of the materials described above and can even be made transparent or translucent.
  • FIG. 93 shows a view of one non-limiting embodiment of the coil spring C shown in FIG. 9, and illustrates the various features thereof.
  • the coil spring C provides a downward bias to aerosol module D-H causing cams 80m, 8On of cutter member H and surfaces 100c, 100d, and 100f of body member J to determine the vertical position of aerosol module D-H as a function of mouthpiece B rotation.
  • the spring C has a generally circular configuration and is sized and configured to engage the projections 2Oi of the member B and the surface 80a of member H.
  • the spring C thus functions to bias the cutter mechanism H towards member J.
  • the spring C can be of a configuration which sets the actuation torque (the torque required to rotate the mouthpiece B and actuate the apparatus) within the range of between about 0.3 Nm and about 0.5 Nm, and is preferably set to about 0.33 Nm.
  • the spring C can be made of stainless steel and can have a grade of 302/304. Of course, other configurations and shapes for the spring C are contemplated.
  • the spring O has a generally rectangular base portion formed by two straight generally parallel side sections 15Od and a connecting portion 15Oe. This base portion is designed to rest on a bottom inner surface of member P.
  • the spring O also utilizes two free end portions 150a and 150b which are sized and configured to slide between the plate-like projections 16Oe and 16Of of member P (see, e.g., FIG. 18). These free ends 150a and 150b are configured to be engaged by the two oppositely arranged axial projections 140i and 14Oj of receptacle impacting member N (see, e.g., FIG. 19).
  • Each free end 150a and 150b is connected to the base portion via a connecting coil portion 150c.
  • the coil portion 150c functions as a torsion spring and resists the downward movement of the free ends 150a and 150b.
  • the spring O can be made of stainless steel and can have a grade of 302/304. Of course, other configurations and shapes for the spring O are contemplated. Furthermore, it is also possible to make the spring O of synthetic resin.
  • the spring O can also have the form of a plate instead of being a wire torsion spring.
  • FIGS. 95-98 show various views of one non-limiting embodiment of the body member P shown in FIG. 9, and illustrate the various features thereof.
  • the body member P provides a flat surface on the bottom of the device for labeling.
  • the member P has a generally oval configuration and includes an upper edge 160b and a plurality of slots 16Od which are sized and configured to receive the lower portions of projections 12Oh of member L.
  • Four plate-like projections 16Of and 16Oe are arranged vertically and function to guide the movement of the spring O as well as the receptacle impacting member N (as was described above).
  • Two cross- shaped projections 160c are arranged vertically, and the free ends of these projections 160c are structured and arranged to become fixed or non- removably connected to the portions 100o of member J.
  • the member P additionally also utilizes two oppositely arranged indentations 16Og which function to allow air to enter into the apparatus.
  • Member P When the members P and L are assembled together, there remains a small space between upper edge 160b and shoulder 12Og and a larger space between indentations 16Og and the indentations 12Oj.
  • Member P also utilizes two upward facing projections 160k and 16Oi which have circular recesses 1601 and 16Oj that form bearings for the two ends 13Og of lock member M.
  • the member P can be made of the materials described above and can even be made transparent or translucent.
  • FIG. 99 shows a 3D side perspective view of an embodiment of the trigger E after it has assumed the fully opened position.
  • the trigger E functions as follows: as the patient creates a vacuum in the internal portion of the mouthpiece B, the trigger E inverts and the four "petals" of the trigger open (see also FIGS. 25-26).
  • the primary function of the trigger is to ensure consistent and uniform dosing.
  • FIGS. 100-101 show test results from flow rate tests conducted with the apparatus with and without the trigger E.
  • the trigger E may reset itself when a user fails to draw sufficient airflow into the apparatus, resulting in incomplete or inconsistent aerosolization of the powder contained in the receptacle Q. This phenomenon can typically be avoided by providing sufficient training on the correct inhalation maneuver for operating the apparatus.
  • FIG. 102 shows a top view of a lid stock of a receptacle Q after the receptacle Q is used in the apparatus.
  • the outlet opening in the center has been formed by the puncturing and deoccluding device G (and more specifically by the end 7Og) and the two arc-shaped inlet openings have been formed by the cutter mechanism H (and more specifically by the teeth 8Ot).
  • the member G plunges into the foil lid stock on the top of the receptacle blister pack Q to create the central outlet opening.
  • the two teeth 8Ot of the cutter mechanism H are timed to descend into the foil shortly after or essentially simultaneously with the member G. Such movement is controlled by contact between the corresponding cam surfaces of the members H and J.
  • the member G rotates to displace foil and thereby create a center outlet hole while the teeth 8Ot form two approximately 120° arc-shaped openings which provide inlet for air through the blister pack Q.
  • the teeth 8Ot do not actually cut the foil in forming the inlet openings, but rather propagate a controlled tear as illustrated in FIG. 173.
  • FIG. 103 shows a cut-away view of the lower portion of another embodiment of an apparatus and shows a receptacle Q in the home position and shows a positioning of the components J-Q of FIG. 9.
  • FIGS. 104-107 show a cut-away view of the lower portion of another optional apparatus.
  • This apparatus is similar to that on FIGS. 1-2 except that the receptacle impacting member N is replaced with a differently configured receptacle impacting member. Unlike the previous member, this member does not utilize shoulders at the free ends of the lobes. Furthermore, in this embodiment, the lobes or arms are caused to rotate or move by contact with the tub of the receptacle instead of by contact with the leading end of the receptacle.
  • FIG. 104 shows an initial insertion position of the receptacle.
  • FIG. 105 shows how the receptacle starts causing the lobe to move and how this occurs by contact engagement between the tub and the left-side lobe.
  • FIG. 106 shows how the receptacle continues moving the left-side lobe to center or vertical position (i.e., the position which causes maximum compression of the torsion spring O) and how this occurs by contact engagement between the tub and the lobe.
  • FIG. 107 shows the receptacle in the home position. After the receptacle moved the left-side lobe past the center or vertical position, the torsion spring O automatically released its energy causing the left-side lobe of FIG. 106 to rotate rapidly and impact or strike the tub of the receptacle Q with the lobe. This occurred when the receptacle was in a position intermediate of the positions shown in FIGS. 106 and 107.
  • FIGS. 108-111 show various views of one non-limiting embodiment of a receptacle Q as shown in FIG. 9, and illustrate the various features thereof.
  • the receptacle Q has a generally rectangular configuration and includes a leading end 170c having two oppositely arranged tapered or chamfered edges 17Of which are sized and configured to engage and spread apart the ends 130a of the lock member M.
  • Two generally oppositely arranged recesses 17Og are arranged to receive therein the ends 130a of the lock member M after the ends 130a slidably engage the side edges 170b.
  • the receptacle Q additionally also utilizes a generally spherical tub portion 17Oh which have a generally flattened bottom portion 17Oi.
  • the tub portion is sized and configured to contain therein a desired amount of the powder which will be aerosolized by the apparatus.
  • the recesses 17Og and the tub portion 17Oh may be formed simultaneously, e.g., at a stamping and cutting station, or in series, e.g., at separate stamping and cutting stations.
  • the receptacle Q also utilizes a tab or gripping portion that includes a rear edge 17Od and oppositely arranged side edges 170a.
  • An optional recess 17Oe can be utilized on the read edge 17Od.
  • the end of the receptacle Q opposite the leading end does not utilize chamfered corners (like the leading end) so as to prevent improper insertion of the receptacle Q into the apparatus (without the chamfered corners, this end of the receptacle Q will not act to spread the arms of the lock member M).
  • the upper surface of the receptacle is heat sealed with a foil lid stock.
  • the receptacle Q can also be made of the same material and have substantially the same width as the conventional ExuberaTM receptacle or single-use blister pack.
  • the receptacle Q can utilize the leading taper 17Of and one notch 17Og on only one side of the receptacle Q.
  • the receptacle Q can be made of the materials described above and can even be made transparent or translucent.
  • the receptacle may be made out thermoplastic materials, such as clear thermoplastic, or other clear materials.
  • the apparatus can also utilize a lockout or receptacle locking feature or system of the type used in one or more of the PDS devices described above.
  • the tub shape should be a simple shape preferably made up of circular areas and straight lines; regions of re-circulating flow within the tub should be minimized; the design should be such that there is a constant accelerating flow in the tube that this flow should continue up through the feed tube FT; areas of boundary layer separation should also be minimized and/or avoided as regards the air flow within the tub and into and through the feed tube FT; sudden expansions of air flow within the tub which produce eddies that are slower are acceptable as they provide more room for expansion.
  • the receptacle Q can also be pressurized.
  • FIG. 112 shows an air flow path through the blister itself and the apparatus. Air enters the two 120° arc-shaped inlet openings (see FIG. 102) out the center opening and into the feed tube FT (i.e., the centrally disposed tube of member J) drawing with it fluidized powder from the receptacle or blister pack Q. The flow then moves up through the feed tube FT and through the central opening of the orifice member F, through the trigger E, out through the mouthpiece B, and finally into the lungs of the user. As the powder-laden air passes through the orifice member F and the trigger E, larger agglomerated particles of the powder are deagglomerated to create a fine aerosol suitable for deposition in the deep lung.
  • the feed tube FT i.e., the centrally disposed tube of member J
  • FIG. 113 shows both an air flow path through the blister itself and a bypass air flow path through the apparatus of the type shown in FIGS. 1 and 2.
  • the bypass air flow is designed to reduce the overall air flow resistance of the apparatus in order to improve patient comfort.
  • the bypass air enters the apparatus through gaps in the components (underneath the skirt L) and then passes up through the six openings 8Oe in the cutter mechanism H.
  • the bypass air flow also serves to focus the central flow of aerosol. Note that the leak paths shown in FIG. 113 are intended to be minimized.
  • the main contributors to aerosol performance are the ratio of blister flow to total flow (controlled by the size of the bypass holes 8Oe in the cutter mechanism H), the size of the central opening in orifice member F, and the length of the slits 50c and 5Od on the trigger E.
  • the apparatus shown in FIG. 1 can have a blister flow of about 40%, a trigger slit length of about 0.34 inches and a diameter of about 3.8 mm for the central opening of the orifice member F.
  • the invention contemplates utilizing blister/total ratios of between about 20% and about 70% and orifice member F opening diameters of between about 3 mm and about 13 mm.
  • FIGS. 114-123 show various cross-section views of one embodiment of the apparatus shown in FIGS. 1 and 2 in different operating positions.
  • FIGS. 128-138 show an alternative embodiment.
  • the part count of the device is fourteen, including the optional cap. Differences between the embodiments of FIG. 9 and FIG. 128 are discussed below.
  • the ultrasonic staking of the FIG. 9 embodiment has been replaced by an ultrasonic weld.
  • the cruciform shape of projections 2Oh of the FIG. 9 embodiment are replaced by four ribs 2Oh'.
  • a small rib has been lengthened (the central rib of the three in the images above) to provide additional lead-in of the compression spring C during assembly.
  • an adapter F' snaps to retainer member D' to constrain trigger E'.
  • the adapter F' snaps to cutter member H' to constrain deoccluding device G'.
  • the adapter F' and cutter member H' together form a flange to transmit the force of compression spring C to aerosol module D'-H'.
  • the snaps hold the aerosol module D'-H' together while minimizing leaks.
  • the adapter F' has an interrupted flange 60k' added to the outside diameter of the part to allow it to snap to the cutter member H', eliminating the need for glue. Glue is generally not preferred for use in inhalation devices.
  • the adapter F' has two radial ribs 601' that engage features in the cutter member H' to hold the deoccluding device G' in place, eliminating the need for heat staking.
  • the elimination of heat staking reduces the potential for particulate generation during assembly.
  • the outer circumferential rib 6Og of the FIG. 9 embodiment has been eliminated. Eliminating the outer circumferential rib 6Og reduces the surface area of the inside of the aerosol module D'-H', with an associated reduction in device deposition.
  • the geometry of a central part 7Oe' to 7Og' of the deoccluding member G' is the same, but the overall span and shape of the free ends 70a' and 70b' is different.
  • the longer free ends 70a', 70b' allow the deoccluding member G' to be held by the adapter F' and the cutter mechanism H', eliminating the need for heat-staking.
  • the lengthened free ends 70a', 70b' also allow the deoccluding member to be retained in the device even if the aerosol module D'-H' snaps fail.
  • the upper bearing member I' spreads open during assembly to envelop the flange on the body J'. Once welded to the mouthpiece B', the upper bearing member I' is unable to spread open again, thus securely retaining the upper half of the device to the lower half.
  • the upper bearing member I' spins freely on the flange of the body J'. Details on the underside of the upper bearing member I' engage the interlock tabs on the tray K/M' to lock rotation of the mouthpiece B' if the receptacle Q' is partially inserted. Details on the underside of the upper bearing member I' constrain the interlock tabs on the tray K/M' during rotation of the mouthpiece B' to prevent receptacle Q' insertion or removal when the mouthpiece B' is not in the home position.
  • the body J' has a receptacle opening S' shaped to discourage upside-down receptacle insertion.
  • the shape also provides side-to-side receptacle location upon insertion.
  • Holes 100hk' and 100hp' in the vertical walls of the body J' provide snap features for the tray K/M' and baseplate P'.
  • H-shaped recesses 10OhI' in the vertical walls of the body J' provide snap features for the sleeve L'.
  • Rounded grooves 100ha' in the vertical walls of the body J' provide snap features for the cap A'.
  • the reverse rotation tooth detail 100d' is widened to increase the force required to rotate the device in the wrong direction.
  • tray K/M' includes integral protrusions 130a'.
  • Tray K/M' includes vertical slots 110v' on its underside to constrain motion of the receptacle impacting member N'.
  • Cam surfaces 110w' on the underside of the tray K/M' adjacent to the central rectangular opening 110j' engage secondary cams 14Og', 14Oh' on the receptacle impacting member N'. This helps guide the receptacle impacting member N' past the feed tube FT' without stressing the spoke-like members 10Ot', 100u' on the body J' that hold the feed tube FT' in place.
  • Two small wedge-shaped protrusions 130a' on the top side of the tray K/M' help ensure the leading edge of the receptacle Q' engages a recess 140e' in an arm 140a', 140b', or 140c' of the receptacle impacting member N'. Snap details on the front 110x' and rear (not shown) of the tray K/M' retain the tray K/M' in holes 100hk' provided in the body J'.
  • an axle 14Oi', 140j' of the receptacle impacting member N' engages the spring flexures 150a', 150b' in the baseplate P'.
  • Secondary cams 140g', 140h' relieve the stress of the receptacle impacting member N' spring force as the main arm 140a', 140b', or 140c' sweeps past the feed tube FT'.
  • the receptacle impacting member N' is left-right symmetrical, which eliminates potential orientation errors during assembly.
  • arched wings 150a', 150b' of the baseplate P' provide the spring force for the receptacle impacting member N'.
  • other biasing mechanisms may be used to power the receptacle impacting member.
  • FIGS. 180 and 181 show baseplates P' with other bent cantilever mechanisms that provide a spring force.
  • FIG. 182 shows a baseplate P' with a leaf spring mechanism that provides a spring force.
  • the skirt member L' has different features around the internal surfaces to reflect the fact that it is snapped onto the body J', rather than sandwiched between other parts of the assembly.
  • the skirt member L' does not have a central recess (cf., element 12Of of skirt member
  • FIGS. 124-127 show a preferred cutter mechanism H configuration as well as details of a preferred tooth configuration. As is illustrated in the teeth cross-section of FIG. 126, the leading end of each tooth is blunt, e.g., rounded, so as not to cut the foil but instead to produce a controlled tear. FIG. 127 shows one of the teeth with non-limiting dimensions in "mm".
  • Trigger Valve a mechanism for enforcing threshold pressure differential such that no airflow can occur until pressure drop across Trigger Valve exceeds the threshold pressure differential.
  • pressure differential is provided by user-imposed inhalation vacuum.
  • the ideal Trigger Valve remains in the open state, offering air flow resistance below 0.4 sqrt (cm H 2 O)/(liters/min) and preferably below 0.1 sqrt (cm H 2 ⁇ )/(liters/min) until pressure drop across Trigger Valve drops below 5 cm H 2 O and preferably below 1 cm H 2 O.
  • MP Device Mouthpiece.
  • PF Powder Fluidization apparatus for providing powder medicament fluidization, or entraining powder medicament in air stream, independent of powder medicament agglomeration state.
  • PD Powder Deagglomeration apparatus for reducing fluidized powder medicament suspended in air stream to primary particle state or near primary particle state.
  • FR Flow Regulator apparatus for providing variable resistance as a function of pressure differential, where the pressure differential is provided by user imposed inhalation vacuum, such that flow through the Flow Regulator apparatus or flow to the user through the mouthpiece is held constant or within a predetermined relationship of flow rate vs. pressure differential.
  • Airflow Bypass which may be a conduit having predetermined constant flow resistance or flow resistance vs. pressure differential relationship, typically used in a local parallel flow circuit element.
  • Figures 139 through 161 show passive DPI flow architecture in block diagram form, with arrows showing the direction of airflow from air Inlet to Mouthpiece and Exit. Note that each box represents an element that would offer some airflow resistance similar to flow resistance through an orifice, where flow resistance at flow rate Q and pressure drop AP is defined as
  • Figure 139 is a block diagram of the flow architecture of a typical passive DPI, showing simple air Inlet, Powder Fluidization (PF) apparatus, Mouthpiece (MP), and Exit to the mouth of the user.
  • PF Powder Fluidization
  • MP Mouthpiece
  • Figure 140 is a block diagram of the passive DPI having series- parSllel flow architecture previously disclosed in US 6,606,992.
  • An advantage of this series-parallel flow architecture is that total flow of air from the device Exit is predetermined to be a known function of the user-applied inhalation vacuum.
  • the predetermined function may be a simple constant, such that flow of aerosol-laden air from the device Exit is always constant.
  • the predetermined function may have slight positive slope, such , that flow of aerosol-laden air from the device Exit increases slightly with increase in user-applied inhalation vacuum, wherein the slight positive slope may have advantages in perceived user comfort.
  • a disadvantage of the series-parallel flow architecture shown in the block diagram of Figure 140 is that, because of the variable airflow through the Flow Regulator (FR), airflow through the Powder Fluidization (PR) and Powder Deagglomeration (PD) apparatus is variable and dependent on the user- applied inhalation vacuum.
  • FR Flow Regulator
  • PR Powder Fluidization
  • PD Powder Deagglomeration
  • Figure 141 is a block diagram of a purely series flow architecture such that at any time during actuation the airflow through all elements of the device is the same.
  • the inherent disadvantage of a purely series flow architecture is that flow resistances combine in a manner such that overall device flow resistance can be high and negatively affect user comfort.
  • Figures 142 through 145 are other possible embodiments of purely series passive DPI flow architecture.
  • Figure 146 is a block diagram of a passive DPI having series flow architecture as presented in Figure 141 with an additional Air Bypass (AB) arranged in parallel to the Powder Fluidization (PR) apparatus, wherein the Air Bypass is intended to lower the flow resistance to the Powder Fluidization (PR) apparatus, thereby lowering the DPI overall flow resistance.
  • Figures 147 through 150 are block diagrams of passive DPI as further embodiments of the principles described in Figure 146.
  • Figure 151 is a block diagram of a passive DPI having series flow architecture as presented in Figure 141 with an additional Air Bypass (AB) parallel to the Powder Fluidization (PR) apparatus and Powder Deagglomeration (PD) apparatus, wherein the Air Bypass is intended to lower the flow resistance to the combined PR and PD apparatus, thereby lowering the DPI overall flow resistance.
  • Air Bypass Air Bypass
  • Figures 152 through 155 are block diagrams of passive DPI as further embodiments of the principles described in Figure 151.
  • Figures 156 and 157 are block diagrams of passive DPI having series-parallel flow architecture as further embodiments of the principles presented in Figure 140, with the exception that the Flow Regulator (FR) is arranged in series with only the Powder Deagglomerator (PD) apparatus.
  • Figure 158 is a block diagrams of a passive DPI having series- parallel flow architecture as a further embodiment of the principles presented in Figure 140, with the exception that the Trigger Valve (TV) is arranged downstream of the Powder Deagglomerator (PD) and just upstream of the Mouthpiece (MP).
  • TV Trigger Valve
  • Figures 159 and 160 are block diagrams of passive DPI having series flow architecture as further embodiments of the principles presented in Figure 231 , with the exception that the Flow Regulator (FR) is combined with the Powder Deagglomerator (PD) such that the same apparatus performs both functions.
  • FR Flow Regulator
  • PD Powder Deagglomerator
  • Figures 161 and 162 are block diagrams of passive DPI having series-parallel flow architecture as further embodiments of the principles presented in Figures 159 and 160, with an additional Air Bypass (AB) arranged in parallel to the Powder Fluidization (PR) apparatus, wherein the Air Bypass is intended to lower the flow resistance to the Powder Fluidization (PR) apparatus, thereby lowering the DPI overall flow resistance.
  • Figures 159 through 162 are arrangements that reflect a preferred embodiment.
  • Figures 163 through 168 are block diagrams of passive DPI having flow architecture as further embodiments of the principles presented in Figures 140 through 162 without the inclusion of Flow Regulator (FR).
  • Figures 169 through 171 are block diagrams of passive DPI having flow architecture as further embodiments of the principles presented in Figures 140 through 162, but modified by combining PD and TV functions into a single apparatus.
  • accelerating flows have been found to be most effective for deagglomeration. Such accelerating flows may be accomplished by applying a pressure drop across a simple orifice through which the aerosol, as fluidized powder, is introduced. See Figure 172.
  • the Powder Deagglomerator (PD) is combined with Flow Regulator (FR) such that the same apparatus performs both functions.
  • FR Flow Regulator
  • Figure 174 is an illustration of the same example of this combined FR/PD embodiment in a view from the inlet side, showing the approximate configuration of the orifice during actuation of the passive DPI.
  • One advantage of this combined FR/PD stage especially when the materials used are flexible and inert, such as silicone rubber, the orifice will recover to the approximate shape shown in Figure 173 after actuation of the passive DPI, such that the orifice of the FR/PD will tend to be self-deoccluding.
  • One embodiment of combined PD/TV apparatus is shown as inverting silicone rubber valve in closed position in Figure 175.
  • Figure 176 shows said silicone rubber valve in open position, with arrow indicating the direction of the flow of air through the orifice acting as Powder Deagglomeration (PD) apparatus.
  • PD/TV apparatus as silicone rubber valve to the shape shown in Figure 175 when delivery of powder medicament is completed will tend to keep PD/TV apparatus clean.
  • the flow of air through Airflow Bypass (AB) may be used to provide a sheath of clean air around the aerosol flow approaching the PD or FR/PD apparatus, whether simple orifice or variable area orifice, to further help keep the orifice clean and free of powder otherwise subject to sticking to the orifice because of possible impaction with the orifice.
  • Figure 177 One embodiment utilizing clean air from Air Bypass (AB) is shown in Figure 177, showing one possible arrangement of PF, AB and PD sections of the embodiments shown in Figures 165 and 166.
  • Figure 177 shows PF apparatus consisting of blister pack well 20 containing powder 10 with blister pack lid 40 having cut inlet hole 30 and uptake tube 45, AB apparatus consisting of inlet hole 50 into chamber 60, and PD apparatus consisting of orifice 70 and diffuser 80.
  • Figure 178 Another embodiment utilizing clean air from Air Bypass (AB) is shown in Figure 178, showing one possible arrangement of PF, AB and PD sections of the embodiments shown in Figures 165 and 166.
  • Figure 178 shows PF apparatus consisting of blister pack well 20 containing powder 10 with blister pack lid 40 having cut inlet hole 30 and uptake tube 45, AB apparatus consisting of inlet hole 50 into chamber 60, and FR/PD apparatus consisting of Flow Regulator with deagglomerating orifice 75 and diffuser 80.
  • FR/PD apparatus could be replaced with PD/TV apparatus as shown in flow architecture in Figure 171.
  • the invention also provides for any apparatus, such as an inhaler, which includes at least one of the following features: a mechanism configured to create at least one air inlet opening in a wall of a receptacle by puncturing and tearing, whereby the tearing bends torn edges of the at least one air inlet opening inwardly as described herein; a deoccluding device arranged within a feed tube as described herein; a receptacle impacting device as described herein; and a receptacle lock system as described herein.
  • the present invention is able to passively administer low doses of powder, such as less than 3 mg, less than 2 mg, or less than 1 mg.
  • illustrated features in the drawings are to relative scale.
  • Pulmosol powders correspond to spray-dried insulin powder comprising insulin, mannitol, glycine, and sodium citrate.
  • the below PulmoSphere powders comprised amphotericin B, distearoylphosphatidylcholine (DSPC), calcium chloride, and perfluorooctane bromide (PFOB).

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
EP09722897A 2008-03-21 2009-03-18 Pulverdispersionsgerät Withdrawn EP2257326A2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7026008P 2008-03-21 2008-03-21
US12607808P 2008-04-30 2008-04-30
PCT/US2009/001716 WO2009117112A2 (en) 2008-03-21 2009-03-18 Powder dispersion apparatus, method of making and using the apparatus, components that can be used on the apparatus and other devices, and various active agents

Publications (1)

Publication Number Publication Date
EP2257326A2 true EP2257326A2 (de) 2010-12-08

Family

ID=40792785

Family Applications (1)

Application Number Title Priority Date Filing Date
EP09722897A Withdrawn EP2257326A2 (de) 2008-03-21 2009-03-18 Pulverdispersionsgerät

Country Status (2)

Country Link
EP (1) EP2257326A2 (de)
WO (1) WO2009117112A2 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5570996B2 (ja) 2007-12-14 2014-08-13 エアロデザインズ インコーポレイテッド エアロゾル化可能な食料品の送達
US8399006B2 (en) 2009-01-29 2013-03-19 Forsight Vision4, Inc. Posterior segment drug delivery
US8623395B2 (en) 2010-01-29 2014-01-07 Forsight Vision4, Inc. Implantable therapeutic device
US10166142B2 (en) 2010-01-29 2019-01-01 Forsight Vision4, Inc. Small molecule delivery with implantable therapeutic device
PT105065B (pt) 2010-04-26 2012-07-31 Hovione Farmaciencia S A Um inalador simples de cápsulas
SI2600812T1 (sl) 2010-08-05 2021-12-31 ForSight Vision4, Inc., Naprava za zdravljenje očesa
JP6111194B2 (ja) 2010-08-05 2017-04-05 フォーサイト・ビジョン フォー・インコーポレーテッド 組み合わせ薬物送達方法および装置
EP3861969A1 (de) 2010-08-05 2021-08-11 ForSight Vision4, Inc. Injektorvorrichtung zur arzneimittelabgabe
US8689439B2 (en) 2010-08-06 2014-04-08 Abbott Laboratories Method for forming a tube for use with a pump delivery system
US8372845B2 (en) 2010-09-17 2013-02-12 Novartis Ag Pyrazine derivatives as enac blockers
US8377000B2 (en) 2010-10-01 2013-02-19 Abbott Laboratories Enteral feeding apparatus having a feeding set
US8377001B2 (en) 2010-10-01 2013-02-19 Abbott Laboratories Feeding set for a peristaltic pump system
WO2012068549A2 (en) 2010-11-19 2012-05-24 Forsight Vision4, Inc. Therapeutic agent formulations for implanted devices
JOP20120023B1 (ar) 2011-02-04 2022-03-14 Novartis Ag صياغات مساحيق جافة من جسيمات تحتوي على واحد أو اثنين من المواد الفعالة لعلاج امراض ممرات الهواء الانسدادية او الالتهابية
EP4249059B1 (de) 2011-06-28 2025-07-30 ForSight Vision4, Inc. Vorrichtung zum sammeln einer flüssigkeitsprobe aus einer reservoirkammer einer therapeutischen vorrichtung für das auge
RS61758B1 (sr) 2011-09-16 2021-05-31 Forsight Vision4 Inc Aparati za razmenu tečnosti
US10010448B2 (en) 2012-02-03 2018-07-03 Forsight Vision4, Inc. Insertion and removal methods and apparatus for therapeutic devices
US8809340B2 (en) 2012-03-19 2014-08-19 Novartis Ag Crystalline form
HK1212348A1 (en) 2012-12-19 2016-06-10 Novartis Ag Autotaxin inhibitors
CA2905496A1 (en) 2013-03-14 2014-09-25 Forsight Vision4, Inc. Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
ES2972168T3 (es) 2013-03-28 2024-06-11 Forsight Vision4 Inc Implante oftálmico para administración de sustancias terapéuticas
US20160168119A1 (en) 2013-07-18 2016-06-16 Novartis Ag Autotaxin inhibitors
MX368059B (es) 2013-07-18 2019-09-18 Novartis Ag Inhibidores de autotaxina que comprenden un núcleo de anillo heteroaromático de bencil-amida cíclica.
US20170037030A1 (en) 2014-04-24 2017-02-09 Novartis Ag Autotaxin inhibitors
EP3169289B1 (de) 2014-07-15 2020-04-15 ForSight Vision4, Inc. Augenimplantateinführungssystem
BR112017002466A2 (pt) 2014-08-08 2017-12-05 Forsight Vision4 Inc formulações estáveis e solúveis de inibidores da tirosina cinase do receptor, e métodos para a sua preparação
WO2016077371A1 (en) 2014-11-10 2016-05-19 Forsight Vision4, Inc. Expandable drug delivery devices and method of use
RU2715687C2 (ru) * 2015-04-15 2020-03-02 Филип Моррис Продактс С.А. Порошковый ингалятор и способ его применения
CA3005238A1 (en) 2015-11-20 2017-05-26 Forsight Vision4, Inc. Porous structures for extended release drug delivery devices
JP7009384B2 (ja) 2016-04-05 2022-01-25 フォーサイト・ビジョン フォー・インコーポレーテッド 移植可能な眼薬送達デバイス
US10898494B2 (en) * 2016-05-05 2021-01-26 Liquidia Technologies, Inc. Dry powder treprostinil for the treatment of pulmonary hypertension
KR20200093581A (ko) 2017-11-21 2020-08-05 포사이트 비젼4, 인크. 확장 가능한 포트 전달 시스템을 위한 유체 교환 기기 및 사용 방법
CN111834656B (zh) * 2020-07-25 2022-03-22 山东交通学院 一种优化的单相掺杂镓酸镧电解质制备装置及方法
USD1033637S1 (en) 2022-01-24 2024-07-02 Forsight Vision4, Inc. Fluid exchange device
WO2025096521A1 (en) * 2023-10-30 2025-05-08 Insmed Incorporated Medicament delivery device, cover, and methods of medicament delivery

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3888253A (en) * 1972-08-04 1975-06-10 Beecham Group Ltd Device for administration of medicines
JP3488620B2 (ja) * 1998-02-05 2004-01-19 株式会社日立ユニシアオートモティブ 吸入式投薬器
US6668827B2 (en) * 2000-05-16 2003-12-30 Nektar Therapeutics Systems devices and methods for opening receptacles having a powder to be fluidized
FR2877925B1 (fr) * 2004-11-16 2008-09-19 Valois Sas Dispositif de distribution de produit fluide.
RU2463085C2 (ru) * 2006-10-25 2012-10-10 Новартис Аг Аппарат для распыления порошка, способ его изготовления и применения и его компоненты

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2009117112A3 *

Also Published As

Publication number Publication date
WO2009117112A2 (en) 2009-09-24
WO2009117112A3 (en) 2010-04-22

Similar Documents

Publication Publication Date Title
WO2009117112A2 (en) Powder dispersion apparatus, method of making and using the apparatus, components that can be used on the apparatus and other devices, and various active agents
AU2007309412B2 (en) Powder dispersion apparatus, method of making and using the apparatus, and components that can be used on the apparatus and other devices
EP1615689B1 (de) Medikamentenspender mit ausrichtungsführung zum durchstechen einer kapsel
US7516741B2 (en) Aerosolization apparatus with feedback mechanism
US20100287884A1 (en) Powder conditioning of unit dose drug packages
USRE47526E1 (en) Aerosolization apparatus with air inlet shield
US20110277752A1 (en) Receptacle for an aerosolizable pharmaceutical formulation
US8869794B1 (en) Aerosolization apparatus with capsule puncturing member
CN101588831A (zh) 粉末喷散器具、制造和使用该器具的方法以及可用在该器具和其它装置上的部件
AU2012258357B2 (en) Powder conditioning of unit dose drug packages
AU2004229512B2 (en) Aerosolization apparatus with capsule puncture alignment guide

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20101022

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA RS

17Q First examination report despatched

Effective date: 20110222

DAX Request for extension of the european patent (deleted)
RIN1 Information on inventor provided before grant (corrected)

Inventor name: UNG, KEITH TRY

Inventor name: COHEN, GAL

Inventor name: WEERS, JEFFRY G.

Inventor name: MALTZ, DAVID S.

Inventor name: PAKALA, NEERAJ R.

Inventor name: POSTICH, MARK

Inventor name: RAO, NAGARAJA

Inventor name: FOSS, WILLARD, R.

Inventor name: WILKINS, JONATHAN

Inventor name: PALMER-FELGATE, JOHN

Inventor name: AXFORD, GEORGE, S.

Inventor name: ALSTON, WILLIAM, W.

Inventor name: GLUSKER, MARK

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20121030